Abstract
Background:
Osteochondral defects, involving both cartilage and subchondral bone, remain clinically challenging due to the poor intrinsic healing capacity of cartilage and the limited durability of traditional treatments. This systematic review aims to evaluate current advancements in nano-hydrogel formulations for osteochondral repair, focusing on their composition, preparation methods, mechanical properties, biocompatibility, and regenerative outcomes.
Methods:
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search was conducted across PubMed, Web of Science, and Scopus. Eligible studies were screened based on predefined inclusion and exclusion criteria. The methodological quality and risk of bias of included studies were assessed using CAMARADES checklist, which considered factors such as randomization, blinding, animal welfare compliance, outcome reporting, and study reproducibility. Data synthesis was performed through structured tabulation and subgroup stratification by scaffold structure (single-phase, bilayered, trilayered, gradient), formulation type (injectable vs. preformed), and polymer origin (natural, synthetic, hybrid).
Results:
A total of 41 studies were included, encompassing both in vitro and in vivo models, with participant numbers ranging from small animal models (e.g., rabbits, rats) to larger preclinical systems. Studies varied in scaffold design, bioactive integration, and fabrication techniques. Most nano-hydrogels demonstrated high biocompatibility, tunable degradation, and enhanced tissue integration. However, heterogeneity in design parameters, lack of standardized outcome measures, and variable reporting quality limited direct comparisons.
Conclusion:
Nano-hydrogels show strong potential as biomimetic scaffolds for osteochondral repair, offering customizable mechanical and biological properties. Nevertheless, the evidence base is limited by study heterogeneity, moderate risk of bias, and lack of standardized protocols, which complicates direct comparison and clinical extrapolation. Future work should focus on long-term validation, functional outcome measures, and development of smart, adaptive materials to support clinical translation.
1 Introduction
Osteochondral defects, characterized by damage to both cartilage and the underlying bone, present a significant clinical challenge due to the limited regenerative capacity of cartilage tissue and the complex architecture of the osteochondral unit (Mano and Reis, 2007; Dinoro et al., 2019; Davis et al., 2021; Liu et al., 2021a). These defects are commonly caused by trauma, osteoarthritis, and other degenerative conditions, leading to pain, reduced mobility, and a decreased quality of life (Verhagen et al., 2003; Martin et al., 2007; Liu et al., 2020). Traditional treatments, such as microfracture surgery, autologous chondrocyte implantation, and osteochondral allografts, often fail to provide long-term solutions, particularly for larger lesions, due to complications such as donor site morbidity, limited graft availability, and incomplete integration with host tissues (Hjelle et al., 2002; Cavendish et al., 2019; Chahla et al., 2019). Consequently, there is a critical need for innovative therapeutic strategies that can effectively promote the regeneration of both cartilage and subchondral bone in a coordinated manner (De Leon-Oliva et al., 2023; Li et al., 2023b).
Recent advances in tissue engineering and regenerative medicine have highlighted the potential of biomaterials to overcome the limitations of conventional therapies (Lynch et al., 2021; Zhang et al., 2021; Cao and Ding, 2022; Luo et al., 2022). Among the various biomaterials explored, nano-hydrogel systems have garnered significant attention due to their unique physicochemical properties and versatility (Chander et al., 2021; Ahmad et al., 2022; Sethi et al., 2023; Rana and De la Hoz Siegler, 2024). Nano-hydrogels are three-dimensional, water-swollen polymeric networks that can be engineered to mimic the native extracellular matrix (ECM) of osteochondral tissues (Liu and Hsu, 2018; Zengin et al., 2021; Hwang and Lee, 2024). Their nano-scale features, high surface area, and tunable mechanical properties make them ideal candidates for supporting cell adhesion, proliferation, and differentiation (Quazi and Park, 2022; Hwang and Lee, 2024). Additionally, nano-hydrogels can be easily functionalized to deliver therapeutic agents, such as growth factors, cytokines, and nanoparticles, in a controlled and sustained manner, further enhancing their regenerative potential (Lee, 2018; Soni et al., 2022).
The design and development of nano-hydrogels for osteochondral repair involve several key considerations, including mechanical strength, biodegradability, biocompatibility, and the ability to support dual regeneration of cartilage and bone (Yue et al., 2020; Xiang et al., 2022; Yao et al., 2023). Successful regeneration requires a scaffold that not only mimics the structural and functional properties of the native tissue but also degrades at a rate that matches the pace of tissue formation, thereby providing support throughout the healing process (Yue et al., 2020; Hwang and Lee, 2024). Furthermore, the incorporation of bioactive molecules that can modulate the local cellular environment is essential for promoting chondrogenic and osteogenic differentiation, ensuring effective integration of the scaffold with host tissues (Yue et al., 2020; Xiang et al., 2022).
While numerous studies have reported the development of nano-hydrogel systems for osteochondral repair, there remains a lack of comprehensive understanding regarding the optimal design parameters and functionalization strategies (Wang et al., 2022b). Additionally, the variability in experimental models and evaluation criteria across studies has made it challenging to compare outcomes and draw definitive conclusions about the efficacy of different approaches (Hwang and Lee, 2024). To address these gaps, this systematic review aims to provide a detailed overview of the current status of nano-hydrogel preparations for osteochondral repair, with a focus on their composition, preparation methods, mechanical properties, biocompatibility, and in vitro and in vivo efficacy.
This review analyzes and synthesizes findings from recent literature, highlighting key advancements and identifying existing challenges in the field. It offers insights into the design principles that guided the development of next-generation nano-hydrogel systems, ultimately contributing to the advancement of more effective and reliable therapeutic solutions for osteochondral defects.
2 Materials and methods
This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009; Moher et al., 2015). A protocol was specified and registered on the database International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42024586563) and is available from: https://www.crd.york.ac.uk/prospero/#myprospero.
2.1 Search strategy
A comprehensive search was conducted across three English-language databases: PubMed, Scopus, and Web of Science. The search focused on identifying studies related to nano-hydrogel systems for osteochondral repair. Search terms included combinations of MeSH and free-text keywords: (“nanohydrogel” OR “nanogel” OR “nano-hydrogel scaffold” OR “nanoscale hydrogel” OR “nano-sized hydrogel” OR “nanocomposite hydrogel”) AND (“osteochondral repair” OR “cartilage regeneration” OR “cartilage repair” OR “osteochondral defect”). Filters were applied to include only English-language publications. A detailed list of search terms and strategies for each database is provided in Supplementary Table S1.
Additionally, reference lists of retrieved articles were manually reviewed to identify any further relevant studies. Two authors (AFA and LQ) independently screened titles and abstracts to assess eligibility based on the inclusion criteria. Full-text articles were further reviewed to exclude any duplicates or studies that did not meet the criteria (Figure 1). Discrepancies were resolved through discussion with a third reviewer (JH). The last update search was conducted on 29 September 2024.
FIGURE 1
2.2 Focused question
This systematic review was performed to address the following focused question: “What is the current status of nano-hydrogel preparations in promoting osteochondral repair, specifically regarding their composition, preparation methods, mechanical properties, biocompatibility, and therapeutic efficacy?”
2.3 Selection criteria
To ensure the inclusion of high-quality and relevant studies, specific eligibility criteria were established prior to the screening process. Studies were included if they were original research articles published in peer-reviewed journals, written in English, and focused on the preparation and application of nano-hydrogel systems specifically for osteochondral or cartilage repair. Eligible studies were required to provide sufficient detail on the hydrogel’s composition, crosslinking or functionalization strategies, and report at least one form of biological or functional evaluation, whether in vitro, ex vivo, or in vivo.
Studies were excluded if they were review articles, conference abstracts, dissertations, clinical case reports, editorials, or other forms of grey literature. Additionally, publications that did not focus on osteochondral repair, or those that lacked essential data on hydrogel characterization or biological performance, were omitted. There were no restrictions on publication year; however, only articles published in English were considered. These criteria were designed to ensure methodological rigor and relevance to the focused research question.
2.4 Screening methods and data extraction
Titles and abstracts were screened by two independent reviewers (AFA and LQ), followed by full-text assessments for studies that met the inclusion criteria. Disagreements on study eligibility were resolved through consultation with a third reviewer (JH). The extracting data were following PICO (P: sources, I: interventions, C: control study, O: outcomes) standards.
The data extraction process focused on gathering information about general study characteristics, including nano-hydrogel composition, types of nanoparticles, preparation methods, crosslinking strategies, and controlled release mechanisms. It also covered mechanical and bioactivity properties, such as mechanical strength, degradation rates, biocompatibility, swelling ratios, and functionalization aspects. For in vitro studies, details on cell types, culture conditions, cell viability, and proliferation were collected. In vivo studies were evaluated based on animal models, group allocation, implantation techniques, histological assessments, and outcomes related to subchondral bone and cartilage regeneration, including immunohistochemical findings, inflammation, infection, and hydrogel degradation. Lastly, the extraction included identification of research limitations and recommendations for future studies, ensuring a comprehensive overview of each study’s approach and findings.
2.5 Quality assessment and analysis of the data
The methodological quality of the included studies was evaluated using a customized CAMARADES checklist, which I adapted to better assess the relevance of each study (Macleod et al., 2004). The adapted checklist incorporated 11 key criteria to assess study relevance: (1) publication in a peer-reviewed journal, (2) random allocation to treatment or control groups, (3) blinded outcome assessment, (4) Control of the temperature in the animal facilities, (5) use of appropriate controls, (6) adequate sample size, (7) clear description of the animal model, (8) adherence to animal welfare guidelines, (9) reproducibility and replication of findings, (10) thorough outcome reporting, and (11) disclosure of any potential conflicts of interest. Given the nature of the data, analysis was conducted descriptively, as the variability across studies precluded meta-analysis.
3 Results and discussion
3.1 Search outcomes
Following the removal of duplicates, a total of 1,126 unique publications were identified through database screening. Title and abstract screening narrowed these to 56 articles for full-text evaluation. After applying the inclusion criteria, 11 studies were excluded. Consequently, 41 studies were included in this systematic review (Figure 1). Of these, 34 studies employed both in vitro and in vivo methodologies, while seven were limited to in vitro experiments (Adedoyin et al., 2015; Castro et al., 2015; Kosik-Kozioł et al., 2019; Qin et al., 2020; Fan et al., 2021; Banihashemian et al., 2024; Brown et al., 2024). The assessment of bias showed a spectrum from low to high risk, and detailed findings on methodological quality are illustrated in Figures 2,3, .
FIGURE 2
FIGURE 3
3.2 Nano-hydrogel composition and preparation methods
The studies summarized in Table 1 highlight the structural and compositional diversity of nano-hydrogel systems used for osteochondral repair. These range from simple, single-phase injectable formulations to more complex preformed multilayered scaffolds—each engineered to address distinct mechanical and biological requirements. Scaffold configurations were stratified into single-phase, bilayered, trilayered, and gradient systems. Many bilayered and trilayered constructs were designed to emulate the zonal architecture of osteochondral tissue, allowing site-specific modulation of chondrogenesis and osteogenesis.
TABLE 1
| Nano-hydrogel composition | Nanoparticles used | Formulation type | Polymer origin | Preparation methods and crosslinking strategies | Controlled release | References |
|---|---|---|---|---|---|---|
| Single-phase hydrogel: CuTA@SF hydrogel | Cu nanoparticles | Injectable | Natural | CuTA synthesized by combining Cu nanoparticles with TA; incorporated into SF hydrogel; enzymatically crosslinked using HRP and H2O2 | TA release from CuTA@SF hydrogel monitored using BCA assay | Cao et al. (2023) |
| Bi-layer scaffold: PVA/Col-II/CS (upper), PVA/BCP/CNTs (lower) | BCP, CNTs | Preformed | Hybrid | Freeze–thawing method used to fabricate bi-layer hydrogels, with physical crosslinking | Not explicitly mentioned | Lan et al. (2021) |
| Bi-layer scaffold: IL-4-loaded GelMA (upper), PCL-HA (lower) | HA | Preformed | Hybrid | The bi-layer scaffold was fabricated using two 3D printing techniques: DLP for GelMA and FDM for PCL-HA; physical crosslinking for PCL-HA | IL-4 release from GelMA scaffold monitored over 168 h | Gong et al. (2020) |
| Trilayered scaffold: GL-HPKGN (upper), GL-GMA (middle), GL-HP/GMAAT (lower) | HA | Preformed | Natural | Enzyme crosslinking for upper layer (KGN-Gelatin), photo-crosslinking for middle layer (GMA-Gelatin), dual-crosslinking for lower layer (Atorvastatin-Gelatin) | KGN and AT grafted into the hydrogels, providing sustained release | Chen et al. (2024) |
| LiMn2O4 nanozyme-functionalized bilayer hydrogel scaffold | LiMn2O4 nanozyme, nHA | Preformed | Hybrid | Cartilage layer crosslinked via UV light; subchondral layer crosslinked by Zn2+ and UV light | LiMn2O4 nanozyme was gradually released, reaching 73.2% release by Day 30 | Hu et al. (2024) |
| Bilayered scaffold: top silk fibroin layer; bottom silk-nano (CaP) layer | NanoCaP | Preformed | Natural | Silk-nanoCaP layer prepared with 16 wt% SF and CaP particles; the scaffold was created by salt-leaching and freeze-drying techniques | Not explicitly mentioned | Yan et al. (2015) |
| Tri-layer scaffold: Chi/Col I + II/nHA | nHA | Preformed | Natural | Freeze-drying for bone layer; thermal gelation for calcified cartilage and cartilage layers | Not explicitly mentioned | Korpayev et al. (2020) |
| Bi-layer scaffold: mPEG-b-PLV thermogel | HA | Preformed | Hybrid | mPEG-b-PLV thermogel was prepared via ring-opening polymerization; PLGA/HA scaffold was prepared via salt-leaching with HA particles | Sustained release of KGN from thermogel and BMP-2 from PLGA/HA scaffold | Zhang et al. (2022b) |
| Single-phase hydrogel: p (NiPAAm-co-GMA)/PAMAM | Fe3O4 | Injectable | Synthetic | Mixed p (NiPAAm-co-GMA) and PAMAM; dual gelation achieved via thermal and chemical crosslinking | Not explicitly mentioned | Adedoyin et al. (2015) |
| Hybrid scaffold: Zn-AlgMA hydrogel coating DCPD-coated porous Mg alloy | Zn2+ in the Zn-AlgMA | Preformed | Hybrid | Zn-AlgMA hydrogel prepared using zinc ion crosslinking and UV light crosslinking | Controlled release of Mg2+ and Zn2+ from Zn-AlgMA | Zhang et al. (2024) |
| Bi-layer scaffold: DE-incorporated GelMA | DE microparticles (Si ions) | Preformed | Hybrid | GelMA and DE-incorporated scaffolds fabricated using 3D printing technology; DE microparticles filtered and incorporated into GelMA solution | Continuous release of Si ions from DE microparticles | Deng et al. (2024) |
| Composite gel containing PCL-chit-PEGb-antiCD44 microparticles | PCL-CS microparticles | Injectable | Hybrid | PCL-CS nanofibers prepared by electrospinning, then cryogenically grinded into microparticles, followed by modification with PEG and anti-CD44 antibody | Not explicitly mentioned | Filová et al. (2020) |
| Single- and dual-layer hydrogel–PCL composite scaffold: Heparin-containing PEGDA hydrogel | Heparin (sulfated glycosaminoglycan) | Preformed | Hybrid | Hydrogel synthesized with PEGDA, dithiothreitol for hydrolytic degradation; scaffolds printed using selective laser sintering | Sustained release of heparin-bound small molecules over 14 days | Brown et al. (2024) |
| Bi-layer scaffold: Upper (HLC-HA), Lower (HLC-HA-HAP) | nHA | Preformed | Natural | Liquid phase synthesis, freeze-drying, and chemical crosslinking with EDC/NHS | Not explicitly mentioned | Liu et al. (2021a) |
| Bi-layer-like: GTU-Fe hydrogel film with spatial in situ deposition of KGN@PDA (top) and miRNA@CaP (bottom) | KGN@PDA and miRNA@CaP | Preformed | Natural | In situ deposition of drug and gene nanoparticles on the supramolecular-assembled UPy-GelMA hydrogel | Controlled release of KGN and miR-26a; cumulative release over 7 days | Kang et al. (2024) |
| Bi-layer scaffold: ECM hydrogel-coated ECM/PCL (upper cartilage) + MgO@PDA/PCL (lower bone) | MgO nanoparticles | Preformed | Hybrid | 3D-printed PCL scaffold incorporating MgO@PDA for the subchondral bone layer and ECM hydrogel for the cartilage layer | Sustained release of Mg2+ from the MgO@PDA | Li et al. (2023a) |
| Bi-layer scaffold: Alginate-nHA with CS-hyaluronic acid | nHA | Preformed | Natural | Alginate and nHA scaffold for subchondral phase; CS-HA scaffold for chondral phase; both layers assembled using fibrin glue | Not explicitly mentioned | Banihashemian et al. (2024) |
| Triple-phase hydrogel: In situ synthesized nHA/collagen/alginate hydrogel | nHA | Injectable | Natural | In situ synthesis of nHAp in collagen gel followed by addition of alginate and crosslinking with Ca2+ ions | Not explicitly mentioned | Zheng et al. (2014) |
| Single-phase: Nanosilicate-reinforced silk fibroin (SF-MMT) hydrogel | Montmorillonite (MMT) | Injectable | Natural | Enzymatically crosslinked SF-MMT hydrogel prepared by mixing SF with MMT and crosslinking via HRP and H2O2 | Not explicitly mentioned | Sheng et al. (2022) |
| Single-phase: High-porosity GelMA hydrogel with 5% methacrylated n-HApMA and ADSCs | nHA and nHAMA | Injectable | Natural | Surface modification of nHA using alkylation; bio-inks prepared by incorporating nHAMA and adipose-derived stem cells (ADSCs) into high-porosity GelMA | Not explicitly mentioned | Zheng et al. (2023) |
| Single-phase: GelMA hydrogel loaded with IGF-1 bioactive supramolecular nanofibers (BSN-GelMA) | IGF-1 bioactive supramolecular nanofibers (IGF-1bsn) | Injectable | Hybrid | Supramolecular nanofibers synthesized via solid-phase peptide synthesis; incorporated into GelMA hydrogel using photo-initiator LAP | Sustained release of IGF-1bsn from hydrogel for enhanced regeneration | Wu et al. (2023) |
| Bi-layer scaffold: Double-network hydrogel scaffold | hADSC-derived exosomes | Preformed | Hybrid | 3D printing with dECM bioinks (Hydrogel-DCM and Hydrogel-DBM) incorporating exosomes; crosslinked with GelMA and HA derivatives | Sustained release of exosomes from the hydrogel scaffold over 24 days | Li et al. (2023b) |
| Multileveled hierarchical hydrogel with continuous nHA gradients | Superparamagnetic HA (MagHA) nanorods | Preformed | Hybrid | Hydrogel matrix fabricated using 3D printing; MagHA gradient formed under magnetic force; acrylated disodium pamidronate (ADP) used for covalent bonding with GelMA hydrogel | Not explicitly mentioned | Zhang et al. (2023a) |
| Bilayered hydrogel composed of nHA, CS, and PEGDA | nHA | Preformed | Natural | Hydrogels prepared via Schiff-base reaction (CEC + OHA) and PEGDA photocrosslinking for osteochondral scaffold construction | Not explicitly mentioned | You et al. (2018) |
| Bi-layer scaffold: KGN-loaded GelMA hydrogel | HA | Preformed | Natural | GelMA hydrogels were crosslinked with LAP under UV light; PCL scaffold was 3D printed and coated with HA using alternate soaking technology | Sustained release of KGN from GelMA hydrogels | Zhang et al. (2023b) |
| Gradient scaffold: Alginate/PVA SIPN hydrogel formed in situ | nHA and chondroitin sulfate | Injectable | Hybrid | In situ semi-interpenetrating network (SIPN) hydrogel with gradient CS and nHA integration via wet chemical precipitation and calcium crosslinking | Not explicitly mentioned | Radhakrishnan et al. (2018) |
| Gradient scaffold: 3D printed gradient nHA hydrogel scaffold | nHA | Preformed | Hybrid | 3D bioprinting of SA/AM (sodium alginate and acrylamide) hydrogels with CaCl2 crosslinking and gradient nHA loading via electronic spray method | Not explicitly mentioned | Zhang et al. (2021) |
| Single-phase: Alginate-GelMA hydrogel with 0.5% β-TCP for modeling calcified cartilage | β-Tricalcium phosphate (TCP) | Preformed | Hybrid | Bioink formulation with 6% GelMA, 4% alginate, and 0.5% TCP microparticles; bioprinted using extrusion-based printing with coaxial needle | Not explicitly mentioned | Kosik-Kozioł et al. (2019) |
| Single-phase: HGM supramolecular gelatin hydrogel loaded with KGN and/or TGF-β1 | Not explicitly used | Injectable | Natural | Hydrogels synthesized using a host-guest macromer approach, with β-cyclodextrin (Ac-β-CD) and GelMA | Sustained release of TGF-β1 and KGN for up to 28 days | Xu et al. (2019) |
| Bi-layer scaffold: Cartilage layer (PLGA/CS hydrogel with tubular pores), Bone layer (nHA-g-PLGA/CS porous scaffold) | Grafted nano-hydroxyapatite (nHA-g-PLGA) | Preformed | Hybrid | PLGA/CS hydrogel for cartilage layer and nHA-g-PLGA/CS scaffold for subchondral bone prepared using electrostatic interaction and crosslinking via EDC/NHS | Not explicitly mentioned | Qin et al. (2020) |
| Bi-layer scaffold: GC hydrogel (CK2.1/β-GP/CS) for cartilage and LL37@LDH/CS for bone | Layered double hydroxide (LDH) | Preformed | Hybrid | CK2.1 was incorporated into the GC hydrogel; LL37 was loaded into the LDH/CS scaffold using freeze-drying and chemical modification techniques | Sustained release of CK2.1 from the GC hydrogel | Liu et al. (2021b) |
| Tri-layer scaffold: CS/Gel/nHA | nHA | Preformed | Hybrid | Multilayer scaffold prepared via iterative layering with crosslinking using NHS/EDC | Not explicitly mentioned | Hu et al. (2022) |
| Tri-layer gradient scaffold: Gradient nHA hydrogel scaffold | nHA | Preformed | Natural | Fabrication of nHA/GelMA scaffold through 3D printing; multi-layer structure created using sedimentation of nHA and photocrosslinking | Not explicitly mentioned | Li et al. (2022) |
| Biphasic hydrogel composed of BRH and CRH | β-Cyclodextrin nanoboxes | Injectable | Natural | CRH (HAMA-based) and BRH (GelMA-based) hydrogels prepared via photocrosslinking, with drug nanoboxes for phase-specific delivery | Sustained release of KGN in the CRH and MLT in the BRH | Liu et al. (2020) |
| Gradient mineralized double-network (DN) hydrogel | HA | Preformed | Natural | Hydrogels prepared using a double-network method, with gradient mineralization achieved through a segmented soaking process | Not explicitly mentioned | Fan et al. (2021) |
| Bi-layer scaffold: Composed of γ-PGA, CMCS, and BC | nHA | Preformed | Hybrid | Hydrogel prepared using γ-PGA, CMCS, and BC via chemical and physical crosslinking; bioactive ions (Mg2+ and Cu2+) introduced to cartilage and bone layers | Sustained release of Mg2+ and Cu2+ for dual regulatory functions | Luo et al. (2022) |
| Bi-layer scaffold: Mussel-inspired tough hydrogel with in situ nHA mineralization | HA | Preformed | Natural | Bilayer hydrogel prepared using a one-pot method; PDA facilitates in situ HA mineralization for subchondral bone repair | Sustained release of BMP-2 and TGF-β3 from hydrogel layers | Gan et al. (2019) |
| Bi-layer scaffold: PEG-DA hydrogel matrix and nHA | nHA | Preformed | Synthetic | 3D printing using fused deposition modeling (FDM) to create a biphasic scaffold with nHA in the osseous layer and TGF-β1 in the cartilage layer | Sustained release of TGF-β1 in the cartilage layer over 21 days | Castro et al. (2015) |
| Bi-layer scaffold: PLGA and nHA | nHA | Preformed | Synthetic | PLGA and PLGA/nHA microspheres were prepared using the oil-in-water emulsion/solvent evaporation method | Not explicitly mentioned | Shalumon et al. (2016) |
| Tri-layer scaffold: Injectable and self-healing hydrogel (Ta@gel) | TA and HA | Preformed | Hybrid | Injectable and Ta@gel, combined with 3D-printed HA scaffold; BMSCs encapsulated within GelMA microspheres were loaded into Ta@gel | O2 consumption by TA maintains a hypoxic microenvironment for 20 days | Guo et al. (2024) |
| Single-phase hydrogel: GelMA/Eu-HA nanocomposite hydrogel | Eu-HA nanorods | Injectable | Natural | Hydrothermal synthesis of Eu-HA nanorods, incorporated into GelMA hydrogel via UV crosslinking | Gradual release of Eu ions from Eu-HA nanorods | Jin et al. (2024) |
General study information and methods.
BCP, biphasic calcium phosphate; CS, chitosan; DLP, digital light processing; EU-HA, Europium-doped Hydroxyapatite; GelMA, gelatin methacrylate; HRP, horseradish peroxidase; H2O2, hydrogen peroxide; KGN, kartogenin; nHA, Nano-hydroxyapatite; PCL, polycaprolactone; PDA, polydopamine; PEG-DA, polyethylene glycol diacrylate; PLGA, Poly Lactic-co-Glycolic Acid; hADSC, Human Adipose-derived Stem Cells.
Integration of nanoparticles such as hydroxyapatite (HA), chitosan montmorillonite, silica, and polydopamine (PDA) has been shown to enhance the mechanical integrity, osteoconductivity, and cellular interactions of hydrogels (Shalumon et al., 2016; Gong et al., 2020; Korpayev et al., 2020; Sheng et al., 2022; Hu et al., 2024; Jin et al., 2024). For instance, a study by Cao et al. (2023) utilized Cu-based nanoparticles embedded in a silk fibroin (SF) matrix via enzymatic crosslinking to create a single-phase injectable hydrogel with antioxidative and immunomodulatory properties Similarly, preformed bilayer hydrogels composed of polyvinyl alcohol (PVA), biphasic calcium phosphate (BCP), and carbon nanotubes (CNTs) were fabricated through a freeze-thawing process to generate a gradient interface, mimicking native cartilage–bone transition zones (Lan et al., 2021). These examples illustrate how both formulation type and nanoparticle selection directly influence the functional performance of nano-hydrogels.
The choice of crosslinking strategy is another determinant of scaffold performance, affecting mechanical stability, degradation behavior, and cellular response. Studies included a wide array of crosslinking approaches, enzymatic, photo-initiated, thermal, chemical, ionic, and dual-crosslinking methods, each tailored to the specific polymer systems and application needs (Adedoyin et al., 2015; Xu et al., 2019; Zhang et al., 2022b; Cao et al., 2023; Wu et al., 2023; Chen et al., 2024). For instance, photo-crosslinking has been employed to allow spatially controlled gelation, ideal for constructing gradient or multi-layered hydrogels (Zhang et al., 2024). However as highlighted in multiple reports, optimization is needed to reduce cytotoxicity from residual initiators, which may impact cell viability and tissue integration (Berry et al., 2019; Hu et al., 2019; Tomal and Ortyl, 2020). In terms of polymer origin, systems were broadly classified as natural, synthetic, or hybrid. Natural polymers like chitosan, gelatin (GelMA), alginate, and hyaluronic acid offer favorable biocompatibility and degradation profiles. Synthetic polymers such as PEGDA, PVA, and PLGA provide enhanced mechanical tunability and process control. Hybrid systems, which combine the strengths of both natural and synthetic components, emerged as especially promising in balancing bioactivity with structural integrity, several trilayered and bilayered scaffolds utilized such combinations to achieve distinct zone-specific functions.
Moreover, the application of advanced fabrication methods such as 3D printing, electrospinning, microsphere sintering, and solvent casting enabled precise spatial organization of materials. These techniques facilitated the development of functionally graded scaffolds, often incorporating nano-hydroxyapatite (nHA) or exosome-loaded layers, to mimic the mechanical and biochemical gradients of native osteochondral tissue (Zhang et al., 2022b; Brown et al., 2024). Several preformed multilayered systems were constructed with dual or triple layers, each designed with distinct pore architectures, ion release kinetics, and biofunctional molecules to modulate regeneration in a zone-specific manner.
Collectively, the reviewed studies demonstrate how scaffold architecture (e.g., single-phase, bilayered, trilayered), formulation type (injectable vs. preformed), polymer composition (natural, synthetic, hybrid), nanoparticle inclusion, crosslinking strategy, and fabrication technique can be tailored in concert to engineer next-generation nano-hydrogels for osteochondral repair. This multi-dimensional classification, as summarized in Table 1, provides a comparative framework to inform rational scaffold design and translational scaffold development.
3.3 Mechanical properties and degradation behaviour
Mechanical properties are essential for nano-hydrogel systems, particularly for osteochondral repair, where the scaffold must withstand the mechanical stresses of both cartilage and subchondral bone environments. As observed in Table 2, studies report varied mechanical strengths, with compressive moduli ranging from 0.4 MPa (Mpa) to over 73 MPa depending on the hydrogel composition (Gong et al., 2020; Zhang et al., 2022b; Brown et al., 2024; Hu et al., 2024; Kang et al., 2024). For instance, polycaprolactone-hydroxyapatite (PCL-HA) scaffolds have demonstrated compressive moduli as high as 73 ± 1 MPa, while IL-4-loaded GelMA-PCL-HA composites exhibit lower values around 4.7 ± 0.6 MPa (Gong et al., 2020). These scaffold values are within the range of trabecular (cancellous) bone, which exhibits compressive moduli typically between 10 and 200 MPa, depending on site and density. In contrast, the modulus of natural cortical bone is substantially higher, with a longitudinal elastic modulus ranging from 17.2 to 23.2 GPa and a transverse modulus ranging from 10.8 to 13.9 GPa, as demonstrated through multiscale modeling validated by nanoindentation and ultrasound measurements (Hamed et al., 2010). These comparisons highlight the potential of HA-containing scaffolds to approximate native bone behavior in osteochondral repair applications, particularly when enhanced with structural reinforcements like hydroxyapatite.
TABLE 2
| Mechanical properties | Degradation rate | Degradation condition (Temp/Env’t) | Swelling ratio | References |
|---|---|---|---|---|
| Stable mechanical properties; storage modulus (G′) > loss modulus (G″); viscosity increased with TA and CuTA | 87.9% remained after 70 days in PBS | In an incubator | Swelling equilibrium reached after 72 h | Cao et al. (2023) |
| Tensile modulus: 7.14 ± 3 MPa; compression modulus: lower layer (0.081 MPa) > upper layer (0.011 MPa) | Slower degradation; upper layer degraded faster | In an incubator | Upper layer: 586% ± 52%; Lower layer: 151% ± 7.1% | Lan et al. (2021) |
| Compressive modulus: PCL-HA scaffold: 73 ± 1 MPa; IL-4-loaded GelMA-PCL-HA: 4.7 ± 0.6 MPa | GelMA hydrogels degraded with 23% mass retention by day 56 | Body temperature | Not reported | Gong et al. (2020) |
| Shear modulus: Upper layer (54.4 ± 1.2 Pa), Middle layer (700 ± Pa), Lower layer (1,500 ± Pa) | Upper layer degraded faster; both biodegradable in collagenase | In an incubator | Upper layer: 155.3% ± 12.1%; Lower layer: 123.6% ± 11.9% | Chen et al. (2024) |
| Compressive modulus of GH@LM + GA@HLM hydrogel was 73.53 kPa | Nearly complete degradation by day 30 | In an incubator | Swelling equilibrium reached after 12 h | Hu et al. (2024) |
| Compressive modulus (wet state): 0.4 MPa; storage modulus up to 0.8 MPa | 27% degradation after 7 days in protease XIV solution | In an incubator | Not explicitly mentioned | Yan et al. (2015) |
| Compressive modulus: Bone layer (42.95 ± 4.3 kPa), calcified cartilage (5.41 ± 0.6 kPa), cartilage (1.49 ± 0.3 kPa) | Not explicitly mentioned | In an incubator | Not explicitly mentioned | Korpayev et al. (2020) |
| Compressive modulus of PLGA/HA scaffold: 73.53 kPa; pore size increased during degradation | mPEG-b-PLV thermogel showed 48.4% degradation after 30 days | In an incubator | Not explicitly mentioned | Zhang et al. (2022b) |
| Young’s modulus via unconfined compression; suitable for tissue regeneration | Not explicitly mentioned | In an incubator | Not explicitly mentioned | Adedoyin et al. (2015) |
| Elastic modulus of Mg scaffold: 0.9–8.8 MPa; Zn-AlgMA improved mechanical stability | Gradual degradation in Hank’s solution | In an incubator | Not explicitly mentioned | Zhang et al. (2024) |
| Elastic modulus increased from 493.3 Pa (GelMA) to 1,010.2 Pa (20% DE); Young’s modulus increased from 64.2 kPa to 122.7 kPa | Slower degradation with higher DE concentration | In an incubator | Not explicitly mentioned | Deng et al. (2024) |
| Higher storage modulus with microparticles than fibrin; loss modulus higher in fibrin | Not explicitly mentioned | In an incubator | Not explicitly mentioned | Filová et al. (2020) |
| Compressive strength varies with porosity: 70% (494 kPa), 80% (100 kPa), 90% (20 kPa) | Degraded within 4 weeks at 20 mol% DTT concentration | In an incubator | Increased fold swelling with higher DTT content | Brown et al. (2024) |
| Compressive strength: Bilayer (212.11 ± 13.49 kPa) vs. single layer (87.47 ± 13.29 kPa) | Not explicitly mentioned | In an incubator | Bilayer scaffold: 498.74%; Single-layer: 789.08% | Liu et al. (2021a) |
| Compressive strength of GTU-Fe hydrogel: 2.59 MPa; excellent viscoelasticity | Gradual degradation; sustained release of KGN and miR-26a | In an incubator | Not explicitly mentioned | Kang et al. (2024) |
| Compressive strength: ECM/PCL (0.58 ± 0.02 MPa) and MD/PCL (0.43 ± 0.01 MPa) | Gradual Mg2+ ion release over 12 weeks; rapid in first 4 weeks | In water bath | Not explicitly mentioned | Li et al. (2023a) |
| Compressive modulus of Alg-nHAP: 0.007 ± 0.0002 MPa; higher in Alg-nHAP/CS-HA | 51.58% degradation over 15 weeks in PBS | In an incubator | 10.24-fold increase in swelling over 10 h | Banihashemian et al. (2024) |
| nHCA had highest tensile and compressive modulus compared to others | Not explicitly mentioned | In an incubator | Not explicitly mentioned | Zheng et al. (2014) |
| Compression modulus of SF-MMT: 24.78 ± 4.13 kPa; improved viscoelastic properties | Gradual degradation over 91 days in PBS | In an incubator | Higher swelling ratio than SF alone | Sheng et al. (2022) |
| Compression modulus of nHAMA scaffolds was three times higher than control | Not explicitly mentioned | In an incubator | Not explicitly mentioned | Zheng et al. (2023) |
| Improved compressive strength of GelMA with IGF-1bsn incorporation | Gradual degradation over 12 weeks in vivo | In an incubator | Not explicitly mentioned | Wu et al. (2023) |
| Improved compressive strength with dual crosslinking; stiffness increased | Slower degradation with DCM/DBM; sustained exosome release over 24 days | In an incubator | Improved swelling with DCM/DBM | Li et al. (2023b) |
| Compression modulus increased with HA gradient; Young’s modulus correlated with MagHA content | Gradual degradation; slower with higher MagHA content | In an incubator | Increased swelling with MagHA; faster equilibrium | Zhang et al. (2023a) |
| Compressive modulus: SS (subchondral) ∼ 100.09 ± 5.46 kPa, SC (cartilage) ∼ 50.2 ± 1.31 kPa | Not explicitly mentioned | In an incubator | SC hydrogel: 53.15%; SS hydrogel: 47.85% | You et al. (2018) |
| Compressive modulus of PCL/HA scaffolds: 14.86 ± 1.81 MPa; enhanced mechanical strength | GelMA hydrogel degraded rapidly; PCL/HA stable over 35 days | In an incubator | GelMA hydrogels showed rapid swelling | Zhang et al. (2023b) |
| Compressive modulus at interfacial region: 930 Pa; increased elastic modulus | Gradual degradation in vivo; complete defect closure after 8 weeks | In an incubator | Not explicitly mentioned | Radhakrishnan et al. (2018) |
| Compressive strength of gradient scaffold (G-nHA) ∼900 kPa; tensile strength improved | Gradual degradation over 28 days in PBS | In an incubator | Swelling equilibrium in 7 h; ratio of 6 | Zhang et al. (2021) |
| Compression modulus decreased by 34.5% in TCP-loaded scaffolds; stable viscoelastic properties | Not explicitly mentioned | In an incubator | Swelling reduced by 18% in TCP-loaded scaffolds | Kosik-Kozioł et al. (2019) |
| Compression modulus enhanced by host-guest interactions; resilient and injectable | Gradual degradation over 28 days | In an incubator | Higher swelling ratio than GelMA hydrogels | Xu et al. (2019) |
| Compressive modulus: bone region: 1.95 ± 0.08 MPa; cartilage: 0.85 ± 0.11 MPa | Not explicitly mentioned | In an incubator | Cartilage region showed high liquid uptake | Qin et al. (2020) |
| Compressive strength: LDH scaffolds: 0.43 MPa; increased to 0.48 MPa with LL37 modification | Gradual degradation in vivo after 12 weeks | In an incubator | Not explicitly mentioned | Liu et al. (2021b) |
| Compressive modulus: 0.21–0.53 MPa; optimal scaffolds similar to natural cartilage | Gradual degradation over 8 weeks in lysozyme | In an incubator | Water absorption varied with composition | Hu et al. (2022) |
| Compressive modulus: 12 kPa (top layer) to 76 kPa (bottom layer) | Gradual degradation observed over 8 weeks | In an incubator | Not explicitly mentioned | Li et al. (2022) |
| Compressive modulus: CRH (62.7 kPa), BRH (56.8 kPa); improved with β-CD integration | Gradual degradation over 36 days in simulated joint environment | In an incubator | Not explicitly mentioned | Liu et al. (2020) |
| Compression strength increased with HA concentration; 27 kPa (non-mineralized) to 380 kPa (highly mineralized) | Gradual degradation observed over 28 days | In an incubator | Not explicitly mentioned | Fan et al. (2021) |
| Compressive modulus increased from 0.15 MPa to 0.58 MPa with 5% MgSO4 | Not explicitly mentioned | In an incubator | Swelling rate reduced from 155% to 75% | Luo et al. (2022) |
| Compressive strength: 0.70 MPa; enhanced properties due to PDA and HA | GelMA-PDA/HA hydrogels degraded in 19 days | In an incubator | Low swelling ratio of 180%, minimal distortion | Gan et al. (2019) |
| Compression modulus increased by 61% with 60 wt% nHA; ultimate strength increased by 87% | Gradual sustained degradation allowing bioactive factor release over 21 days | In an incubator | Not explicitly mentioned | Castro et al. (2015) |
| Compressive strength: Virgin scaffolds (142 ± 14 MPa), Composite (62 ± 6 MPa), Osteochondral (85 ± 5 MPa) | Not explicitly mentioned | In an incubator | Not explicitly mentioned | Shalumon et al. (2016) |
| Compressive strength of HAp@PLL scaffold; mechanical strength sustained throughout regeneration | Hydrogel maintained hypoxic microenvironment for up to 20 days | In an incubator | Not explicitly mentioned | Guo et al. (2024) |
| Improved mechanical properties with Eu-HA nanorods in GelMA hydrogel | Gradual degradation in Eu-HA nanocomposite hydrogel | In an incubator | Not explicitly mentioned | Jin et al. (2024) |
Mechanical properties and physical characteristics.
BRH, bone regenerating hydrogel; CRH, cartilage-regenerating hydrogel; EU-HA, Europium-doped Hydroxyapatite; PBS, Phosphate-Buffered Saline; PDA, polydopamine.
Biomimetic designs incorporating GelMA and HA have shown promise in enhancing mechanical stability and bioactivity for bone regeneration applications. GelMA hydrogels, while beneficial for tissue engineering, lack sufficient mechanical strength and osteogenic factors (Wang et al., 2022a). Incorporating HA into GelMA hydrogels improves their mechanical properties, biocompatibility, and osteogenic potential (Suvarnapathaki et al., 2020). Mineralized HA nanofibers further enhance the mechanical and bone regenerative performances of GelMA composites (Wang et al., 2022a). GelMA-based biomaterials can be tailored to overcome challenges in bone tissue engineering, such as insufficient mechanical properties and uncontrolled degradation (Dong et al., 2019). Advanced designs combining GelMA with other materials, like methacrylated HA nanoparticles and l-arginine-based unsaturated poly (ester amide), can create periosteum-mimicking scaffolds with improved mechanical strength, tissue adhesion, and osteogenic-angiogenic coupling effects (Yang et al., 2021). Double-crosslinking and freeze-drying methods have also been widely applied, producing physically and chemically reinforced structures that retain mechanical properties under physiological conditions (Yan et al., 2015; Filová et al., 2020; Zheng et al., 2023).
Balancing degradation rates with tissue regeneration remains another core challenge. An ideal scaffold degrades gradually, transferring mechanical load to newly forming tissue to aid integration (Hu et al., 2022; Li et al., 2022; Banihashemian et al., 2024; Chen et al., 2024). Studies have shown that adjusting crosslinking density and introducing bioactive molecules can customize degradation profiles for specific applications (Radhakrishnan et al., 2018; Zhang et al., 2023a; Zhang et al., 2023b; Deng et al., 2024). For example, Chen et al. developed a trilayered hydrogel with varied degradation rates across layers to replicate the native tissue gradient from cartilage to bone, facilitating sustained cell infiltration and extracellular matrix formation (Chen et al., 2024). Recent research has focused on developing multilayered hydrogel scaffolds to mimic the zonal organization of native cartilage tissue. These scaffolds feature gradients in mechanical properties, extracellular matrix composition, and bioactive factors across layers to guide cell differentiation and tissue formation (Brady et al., 2017; Qiao et al., 2021). Furthermore, a study demonstrated that layer-specific biomaterial compositions could direct a single stem cell population into zone-specific chondrocytes, resulting in native-like cartilage with varying mechanical and biochemical properties (Nguyen et al., 2011). In addition, a study further showed that stiffness gradient hydrogels could induce zone-specific responses in both chondrocytes and mesenchymal stem cells, mimicking cartilage zonal organization (Zhu et al., 2018). These approaches offer promising strategies for engineering complex osteochondral tissues with spatially-varying properties that more closely resemble native tissue structure and function.
Future advancements will likely focus on refining crosslinking techniques, such as enzyme-catalyzed, thermal, and photo-crosslinking, to develop materials that meet both mechanical and degradation needs for effective tissue engineering.
3.4 Biocompatibility and functional characteristics
Nano-hydrogel systems have consistently demonstrated excellent biocompatibility and functional characteristics, making them highly suitable for applications in tissue engineering, particularly in osteochondral regeneration. Studies have reported cell viability rates exceeding 90% and enhanced cell proliferation, supporting the potential of these materials to promote tissue growth and regeneration (Table 3). For example, a study showed that LiMn2O4 nanozyme-functionalized hydrogels effectively supported the proliferation of rat chondrocytes and bone marrow-derived mesenchymal stem cells (BMSCs), promoting cell adhesion and growth (Hu et al., 2024). In addition, in vitro studies have highlighted that nano-hydrogels, such as GH@LM + GA@HLM and Zn-AlgMA, significantly enhance the proliferation of both chondrocytes and BMSCs, while maintaining high levels of cell viability (Hu et al., 2024; Zhang et al., 2024). Similarly, functionalized scaffolds, including those with CK2.1/LL37 and SF-MMT, further promote the regenerative processes of BMSCs and chondrocytes, reinforcing the critical role of scaffold composition in optimizing cellular responses (Liu et al., 2021b; Sheng et al., 2022).
TABLE 3
| Cell types used | Culture conditions | Viability and proliferation | Bioactivity | Functionalization and targeting | References |
|---|---|---|---|---|---|
| BMSCs, chondrocytes | DMEM with 10% FBS, 1% Penicillin/Streptomycin; osteogenic and inflammatory induction | >90% viability; enhanced proliferation in CuTA@SF | Promoted osteogenesis and chondrogenesis | Targeted osteochondral regeneration, cartilage and bone repair | Cao et al. (2023) |
| MC3T3-E1 cells, chondrocytes | Media leached from hydrogel layers over 7 days | >90% viability; enhanced proliferation for both cell types | Promoted osteogenesis and chondrogenesis | Targeted osteochondral regeneration | Lan et al. (2021) |
| L929 fibroblasts, C3H mouse MSCs, mouse chondrocytes | DMEM/F12 with IL-4; osteogenic induction media for MSCs | >97% viability; no significant difference in growth | Promoted anti-inflammatory effects, and chondrogenesis | Targeted osteochondral regeneration | Gong et al. (2020) |
| rBMSCs | Cultured with KGN and AT in induction media for 14 days | >95% viability; good proliferation confirmed | Enhanced chondrogenesis and osteogenesis | Targeted for osteochondral regeneration | Chen et al. (2024) |
| Rat chondrocytes, BMSCs | Treated with ROS inducer H2O2 | >95% viability; high proliferation | Enhanced chondrogenesis and osteogenesis | Designed for osteochondral repair | Hu et al. (2024) |
| rBMSCs | Cultured in basal and osteogenic media for up to 14 days | >90% viability; increase in proliferation over 14 days | Enhanced osteogenesis in silk-nanoCaP layer | Targeted osteochondral repair with distinct layers | Yan et al. (2015) |
| MC3T3-E1 preosteoblasts, ATDC5 chondrocytes | Co-cultured in layers for 7 days, then 21 days | >85% viability; significant increase in metabolic activity | Enhanced chondrogenesis (COL II) and osteogenesis (COL I, ALP) | Designed for osteochondral repair | Korpayev et al. (2020) |
| BMSCs | Cultured in thermogel layer with KGN | High viability maintained | Enhanced chondrogenesis and osteogenesis | Full-thickness osteochondral repair | Zhang et al. (2022b) |
| WRN cells | Encapsulated in hydrogels with Fe3O4 nanoparticles for 48 h | High viability; no cytotoxicity | Fe3O4 nanoparticles exert physiological forces on encapsulated cells | Injectable scaffolds for osteochondral regeneration | Adedoyin et al. (2015) |
| BMSCs | Cultured in osteogenic and chondrogenic media with immersion liquid | >90% viability; proliferation in Zn-AlgMA hydrogel at 10−4 M zinc ion | Enhanced osteogenesis (Mg2+) and chondrogenesis (Zn2+) | Targeted osteochondral repair | Zhang et al. (2024) |
| rBMSCs and chondrocytes | Cultured on GelMA and DE-incorporated scaffolds in induction media | High cell viability observed on 5%–20% DE scaffolds | DE microparticles significantly enhanced chondrocyte proliferation | Dual-layer scaffolds for cartilage and bone regeneration | Deng et al. (2024) |
| Fibrochondrocytes, chondrocytes | Cultured on PCL-chitosan and anti-CD44-modified microparticles | High viability | Anti-CD44 microparticles enhanced osteogenic regeneration | Targeted osteochondral defects | Filová et al. (2020) |
| Porcine chondrocytes | Encapsulated in PEGDA-DTT hydrogels for 7 days | >95% viability | Heparin promoted sustained release and enhanced differentiation | Craniofacial reconstruction, supporting cartilage and bone | Brown et al. (2024) |
| hBMSCs | Cultured in scaffolds with DMEM and supplements | High viability confirmed | Enhanced chondrogenesis and osteogenesis | Targeted osteochondral defect repair | Liu et al. (2021a) |
| MSCs and chondrocytes | Cultured in hydrogel scaffolds | High viability confirmed | Enhanced chondrogenesis and osteogenesis | Targeted osteochondral regeneration | Kang et al. (2024) |
| hBMSCs | Cultured on ECM/PCL and MD/PCL scaffolds | High viability confirmed | ECM/PCL promoted huBMSC proliferation | Targeted osteochondral defects | Li et al. (2023a) |
| hCHCs and hAdMSCs | Cultured in CS-HA and Alg-nHAP scaffolds | High viability | Significant proliferation in both scaffold types | Targeted osteochondral repair | Banihashemian et al. (2024) |
| Chondrocytes from newborn rabbit | Encapsulated in nHCA, HCA, and nHC hydrogels for 21 days | High viability | nHCA showed highest cell proliferation | Targeted osteochondral regeneration | Zheng et al. (2014) |
| BMSCs and chondrocytes | Cultured in SF-MMT and SF with osteogenic induction | >93% viability | Increased proliferation with no significant difference | Targeted osteochondral regeneration | Sheng et al. (2022) |
| ADSCs | Cultured in nHAp and nHApMA bio-inks | High viability confirmed | Enhanced osteogenic and chondrogenic differentiation | Targeted osteochondral regeneration | Zheng et al. (2023) |
| rBMSCs | Cultured in GelMA and GelMA/IGF-1bsn hydrogels for 72 h | High viability confirmed | BSN-GelMA significantly enhanced rBMSC proliferation | Osteochondral regeneration in mosaicplasty | Wu et al. (2023) |
| rBMSCs | Cultured in Hydrogel-DCM and Hydrogel-DBM for 14 days | High viability confirmed | Exosome-loaded scaffolds enhanced proliferation | Targeted osteochondral repair | Li et al. (2023b) |
| BMSCs | Cultured in MagHA-gradient hydrogel for 21 days | High viability confirmed | Significant proliferation in MagHA gradient compared to control | Full-thickness osteochondral regeneration | Zhang et al. (2023a) |
| rBMSCs | Encapsulated in SC and SS hydrogels | >90% viability | Significant proliferation in both hydrogels | Designed for osteochondral regeneration | You et al. (2018) |
| BMSCs | Cultured in KGN-loaded GelMA and HA-coated PCL scaffolds | High viability confirmed | Significant proliferation in both cartilage and bone regions | Targeted osteochondral repair | Zhang et al. (2023b) |
| Rat osteoblasts and caprine chondrocytes | Co-cultured in gradient hydrogel for 21 days | High viability confirmed | Higher proliferation in nHA-enriched hydrogels | Designed for osteochondral regeneration | Radhakrishnan et al. (2018) |
| Goat TMJ disc cells | Cultured in nHA-gradient hydrogels; assessed via MTT and AO/EB staining | High viability confirmed | Increased proliferation in G-nHA scaffold compared to controls | Targeting cartilage and subchondral bone with gradient layers | Zhang et al. (2021) |
| BM-hMSCs | Cultured in chondrogenic media for 21 days | High viability confirmed | Increased proliferation in TCP-loaded scaffolds | Designed for calcified cartilage and subchondral bone regeneration | Kosik-Kozioł et al. (2019) |
| hBMSCs | Encapsulated in HGM and GelMA hydrogels with TGF-β1 or KGN for 14 days | >95% viability | Significant proliferation in HGM compared to GelMA | Injectable for osteochondral regeneration | Xu et al. (2019) |
| hASCs | Seeded into bilayer scaffold with BMP-2 and IGF-1 for 14 days | High viability observed | Cells proliferated and formed spheroids in cartilage region | Sequential chondrogenesis and osteogenesis mimicking natural tissue | Qin et al. (2020) |
| MSCs and HUVECs | Cultured in CK2.1/LL37-loaded scaffolds for 14 days | High viability observed | Enhanced proliferation in CK2.1/LL37 scaffolds | Targeting cartilage and subchondral bone | Liu et al. (2021b) |
| ADSCs | Cultured in multilayer scaffolds in static and dynamic environments | >90% viability | Higher proliferation in dynamic culture compared to static | Layered design for cartilage and subchondral bone targeting | Hu et al. (2022) |
| BMSCs | Cultured in multi-layer scaffold in osteogenic and chondrogenic media | >95% viability | Significant proliferation in both regions | Targeting cartilage and subchondral bone in distinct layers | Li et al. (2022) |
| hMSCs | Encapsulated in CRH and BRH hydrogels for 21 days | >90% viability | Significant proliferation with phase-specific differentiation | Simultaneous regeneration of cartilage and subchondral bone | Liu et al. (2020) |
| BMSCs | Cultured in gradient mineralized hydrogels for 21 days | >95% viability | Good proliferation in non-mineralized and mineralized layers | Mimicking cartilage and subchondral bone regions with gradients | Fan et al. (2021) |
| BMSCs | Cultured in Mg2+- and Cu2+-regulated layers | High viability observed | Enhanced proliferation in regulated hydrogels | Designed for osteochondral regeneration | Luo et al. (2022) |
| BMSCs and chondrocytes | Cultured on GelMA, GelMA-PDA, and GelMA-PDA/HA | High viability confirmed | Significant proliferation in PDA-incorporated hydrogels | Targeting cartilage and subchondral bone in dual-layer structure | Gan et al. (2019) |
| hMSCs | Cultured on PEG-DA scaffolds with nHA and TGF-β1 | High viability; significant proliferation observed | 93% and 53% increase for 40 wt% and 60 wt% nHA | Designed for osteochondral regeneration | Castro et al. (2015) |
| BMSCs and chondrocytes | BMSCs in osteogenic medium, chondrocytes in chondrogenic medium | >90% viability | Significant proliferation in both parts | Designed for osteochondral tissue engineering | Shalumon et al. (2016) |
| BMSCs and chondrocytes | Encapsulated in GelMA microspheres in induction media | >90% viability | Significant proliferation; enhanced differentiation confirmed | Targeting cartilage and subchondral bone for complex regeneration | Guo et al. (2024) |
| Chondrocytes, BMSCs, RAW264.7 macrophages | Cultured in DMEM/F12, α-MEM, and DMEM with 10% FBS | >90% viability | Promotion of chondrocyte proliferation and BMSC differentiation | Designed to facilitate immunomodulation for osteochondral regeneration | Jin et al. (2024) |
Biocompatibility and functional characteristics.
BMSCs, Bone Marrow Mesenchymal Stem Cells; hBMSCs, Human Bone Marrow Mesenchymal Stem Cells; rBMSCs, rabbit Bone Marrow Mesenchymal Stem Cells; BM-hMSCs, Bone Marrow-Derived Human Mesenchymal Stem Cells; hMSCs, Human Mesenchymal Stem Cells; TMJ, temporomandibular joint; hCHCs, Human Chondrocyte-like Cells; hAdMSCs, Human Adipose-derived Mesenchymal Stem Cells; WRN, wnt rspondin noggin cells; hASCs, Human adipose-derived stem cells.
Nano-hydrogels mimicking the extracellular matrix (ECM) have emerged as promising scaffolds for tissue engineering and regenerative medicine. These biomimetic materials create a three-dimensional (3D) environment that closely resembles the native ECM’s nanoscale architecture (Geckil et al., 2010; Gough et al., 2012; Brown et al., 2024). By incorporating nanostructured components, such as nanofibers or nanosilicates, these hydrogels can actively modulate cellular responses, including attachment, proliferation, and differentiation (Wei and Ma, 2008). For instance, nanoengineered collagen-based hydrogels reinforced with disk-shaped nanosilicates have been shown to enhance osteogenic differentiation of human mesenchymal stem cells without the need for exogenous growth factors (Paul et al., 2016). These ECM-mimicking hydrogels not only provide structural support but also create a regulatory milieu that guides tissue formation and organization (Geckil et al., 2010). Furthermore, their biocompatibility and ability to induce regenerative processes make them promising candidates for various biomedical applications, including bone tissue engineering and in vitro disease modeling (Wei and Ma, 2008; Paul et al., 2016).
Furthermore, functionalization techniques are crucial for enhancing the bioactivity of hydrogels in osteochondral tissue engineering. By incorporating growth factors, bioactive molecules, and nanoparticles, these hydrogels can promote both osteogenesis and chondrogenesis. For example, research has shown that embedding polydopamine-encapsulated kartogenin (KGN) and calcium phosphate-encapsulated miRNA-26a within hydrogels effectively promotes regeneration in both cartilage and bone layers (Kang et al., 2024). Additionally, KGN has been grafted onto ultrasmall superparamagnetic iron-oxide nanoparticles, which are then integrated into hydrogels for cartilage repair while enhancing MRI contrast (Yang et al., 2019). Another study developed microscaffold-hydrogel composites containing KGN and peptides to accelerate osteochondral repair through endochondral ossification (Zhang et al., 2022a). Moreover, a versatile hydrogel system using click chemistry has been created to provide tissue-specific cues for either chondrogenesis or osteogenesis (You et al., 2018; Guo et al., 2020; Liu et al., 2021a; Li et al., 2023a). These approaches highlight the potential of functionalized hydrogels in addressing the complex requirements of osteochondral tissue regeneration.
Recent studies demonstrate the effectiveness of functionalized biomaterials in advancing osteochondral repair, primarily by supporting both osteogenic and chondrogenic differentiation. Composite hydrogels with anti-CD44-labeled microparticles have shown to significantly improve osteogenic regeneration in animal models of osteochondral defects (Filová et al., 2020). Likewise, bilayer scaffolds that guide stem cell differentiation spatially have been effective in directing cells into osteogenic and chondrogenic lineages, enhancing repair outcome (Kang et al., 2024; Lowen et al., 2024). Furthermore, microscaffold-hydrogel composites, incorporating bioactive modifications like RGD peptides, have demonstrated accelerated osteochondral repair through endochondral ossification, achieved by controlled delivery of bioactive molecules within the scaffold layers (Zhang et al., 2022a; Brown et al., 2024; Deng et al., 2024). Other studies reinforce these findings, with functionalized hydrogels designed for dual osteogenic and chondrogenic applications showing sustained, layer-specific release of growth factors and bioactive ions, thus promoting cell proliferation and tissue integration (Cao et al., 2023; Wu et al., 2023).
These findings underscore the potential of multi-functionalized nano-hydrogels in tissue engineering, with customizable layers enabling the spatially controlled release of bioactive agents that foster site-specific tissue regeneration. Such approaches pave the way for advanced therapies for osteochondral defects and other complex tissue engineering applications (Wu et al., 2023; Brown et al., 2024).
These findings suggest that nano-hydrogels are capable of providing a supportive 3D microenvironment that mimics the native ECM. However, achieving consistent differentiation and integration remains challenging, particularly when translating in vitro success to in vivo conditions. Variability in cell behavior across studies suggests that more standardized protocols are needed to optimize cell-scaffold interactions, ensuring predictable outcomes in clinical settings.
3.5 In vivo efficacy and regeneration outcomes
The in vivo studies summarized in Table 4 illustrate the promising efficacy of nano-hydrogels in promoting osteochondral repair, using diverse animal models such as rabbits, rats, and mice to assess the regenerative potential of these systems. Significant cartilage regeneration and subchondral bone repair were observed in a rabbit model using a bi-layered GelMA-PCL-HA scaffold, where histological analyses confirmed the formation of a smooth cartilage surface and well-integrated bone layer (Gong et al., 2020). Similarly, a bilayer hydrogel containing GH@LM + GA@HLM demonstrated notable regeneration, with micro-CT and histological assessments indicating smooth hyaline cartilage formation and robust subchondral bone repair (Hu et al., 2024) (Table 4). These advanced hydrogel systems have demonstrated improvements in defect filling, cartilage thickness, and bone regeneration compared to control groups (Gan et al., 2019; Guo et al., 2021). However, a critical review of in vivo cartilage repair studies highlights the need for standardized experimental designs and careful interpretation of results (Vilela et al., 2015).
TABLE 4
| Animal model | Group allocation | Implantation method | Histological assessment | References |
|---|---|---|---|---|
| Rabbits | 5 groups: Control, SF, Cu@SF, TA@SF, CuTA@SF | Pre-formed hydrogels implanted into OCD site | CuTA@SF showed the best integration and cartilage repair | Cao et al. (2023) |
| Rabbits | 3 groups: Blank, PVA hydrogel, Bi-layer hydrogel | Hydrogels implanted into defects created in rabbit knees | Bi-layer group showed better cartilage and bone repair | Lan et al. (2021) |
| Rabbits | 3 groups: Nontreated, bi-layer scaffold, and IL-4-loaded bi-layer scaffold; 8- and 16-week post-surgery observations | Bi-layer scaffold implanted into defects created in rabbit knee joints | IL-4-loaded scaffold group showed better cartilage repair | Gong et al. (2020) |
| Rabbits | 3 groups: Untreated (blank), control, experimental | Trilayered scaffolds implanted into osteochondral defects | Experimental group showed better cartilage and bone repair | Chen et al. (2024) |
| Sprague-Dawley rats | 4 groups: PBS, GH + GA (basic hydrogel), GH + GA@H (with nanohydroxyapatite), GH@LM + GA@HLM (with nanozyme) | Bilayer hydrogels implanted into femoral condyle defects | GH@LM + GA@HLM showed the best cartilage and subchondral bone repair | Hu et al. (2024) |
| Rabbits | 2 groups: bilayered scaffold implantation and defect control (no scaffold) | Bilayered scaffolds were press-fit into osteochondral defects in rabbit knees | Scaffold showed cartilage and subchondral bone regeneration | Yan et al. (2015) |
| BALB/c mice | Specific details are not explicitly mentioned | Multi-layered scaffolds were inserted into subcutaneous pockets created in mice | Staining showed mild inflammatory response with macrophage and neutrophil infiltration | Korpayev et al. (2020) |
| Rabbits | 4 groups: control, Gel/Scaffold, Gel-MSCs/Scaffold, GelKGN-MSCs/ScaffoldBMP-2 | Bilayered scaffolds were implanted into osteochondral defects in the femoral condyle | Staining showed cartilage and subchondral bone regeneration in the GelKGN-MSCs/ScaffoldBMP-2 group | Zhang et al. (2022b) |
| Rabbits | 4 groups: blank control, Zn-AlgMA, DCPD-coated Mg, Zn-AlgMA@Mg scaffold | Scaffolds implanted into osteochondral defects in femoral condyles | Zn-AlgMA@Mg group showed best osteochondral integration | Zhang et al. (2024) |
| Rabbits | 4 groups: blank control, GelMA, 0–10 DE, 5–20 DE scaffolds | Scaffolds implanted in femoral condyle defects | 5–20 DE group showed best osteochondral regeneration | Deng et al. (2024) |
| Rabbits | 3 groups: scaffold #1 (PCL-chit-PEGb), scaffold #2 (PCL-chit-PEGb-antiCD44), control | Scaffolds implanted in femoral condyle defects | PCL-chit-PEGb showed superior hyaline cartilage regeneration, while anti-CD44 favored bone formation | Filová et al. (2020) |
| Rabbits | 3 groups: Control, single-layer scaffold, bilayer scaffold | Bilayer scaffolds implanted into knee joint defects | Bilayer scaffold showed better cartilage regeneration and bone formation | Liu et al. (2021a) |
| Rabbits | 5 groups: Control, GTU-Fe, GTU-Fe/KGN@PDA, GTU-Fe/miRNA@CaP, GTU-Fe/KGN@PDA/miRNA@CaP | Cylindrical GTU-Fe scaffolds implanted into knee defects | GTU-Fe/KGN@PDA/miRNA@CaP showed better cartilage and bone regeneration | Kang et al. (2024) |
| Rats | 5 groups: Blank, PCL, ECM/PCL, MD/PCL, Bilayer scaffold | Bilayer scaffolds implanted into knee joint defects | Bilayer scaffold showed better cartilage and bone regeneration | Li et al. (2023a) |
| Rabbits | 3 groups: Control, SF hydrogel, SF-MMT hydrogel | SF and SF-MMT hydrogels implanted into osteochondral defects in rabbit knees | SF-MMT showed better cartilage and bone regeneration | Sheng et al. (2022) |
| Rabbits | 3 groups: Control, nHAp bio-ink, nHApMA bio-ink | Scaffolds implanted into femoral condyle defects in rabbit knees | nHApMA showed better cartilage and bone regeneration | Zheng et al. (2023) |
| Rabbits | 3 groups: Blank, GelMA hydrogel, BSN-GelMA hydrogel | Mosaicplasty performed on rabbit knee joints | BSN-GelMA showed better gap integration and tissue regeneration | Wu et al. (2023) |
| Rats | 4 groups: Blank, Hydrogel, Bi-Hydrogel, Bi-Hydrogel-Exos | Bilayer scaffolds implanted into osteochondral defects in rat knee joints | Bi-Hydrogel-Exos showed better osteochondral regeneration | Li et al. (2023b) |
| Rabbits | 5 groups: Control, DN hydrogel, bi-phasic hydrogel, MagHA gradient hydrogel with (Gra+) and without (Gra-) magnetic field stimulation | Hydrogel scaffolds implanted into rabbit knee joint defects | MagHA-gradient hydrogel showed enhanced osteochondral regeneration, especially in Gra+ | Zhang et al. (2023a) |
| C57BL/6J mice | Specific details are not explicitly mentioned | SC and SS hydrogels implanted under dorsal skin | Staining showed good integration of hydrogels with surrounding tissue | You et al. (2018) |
| Rabbits | 4 groups: Blank, PCL/GelMA, PCL/GelMA@TA/E7, PCL/HA-GelMA/KGN@TA/E7 | Bilayer scaffolds implanted into knee joint defects | PCL/HA-GelMA/KGN@TA/E7 group showed better cartilage and subchondral bone regeneration | Zhang et al. (2023b) |
| Rabbits | 4 groups: Control, nHA scaffold, ChS scaffold, Gradient (nHA + ChS) scaffold | Hydrogels injected into osteochondral defects in rabbit knees | Gradient scaffold group showed improved collagen and GAG deposition | Radhakrishnan et al. (2018) |
| Rats | 7 groups: Control, BMSCs only, 0% nHA + BMSCs, 40% nHA + BMSCs, 70% nHA + BMSCs, G-nHA only, G-nHA + BMSCs | Scaffolds implanted into rat knee defects | G-nHA + BMSCs group showed better osteochondral regeneration | Zhang et al. (2021) |
| Rats | 4 groups: GelMA with KGN, GelMA with TGF-β1, HGM (Injection) with KGN, HGM (Injection) with TGF-β1 | HGM hydrogels injected into defects in rat knees | HGM groups showed better cartilage and subchondral bone regeneration | Xu et al. (2019) |
| Rabbits | 3 groups: Control, biphasic scaffold without peptide (GC/LC), biphasic scaffold with CK2.1/LL37 (CK2.1@GC/LL37@LC) | Scaffolds implanted into osteochondral defects | CK2.1/LL37 group showed better cartilage and subchondral bone regeneration | Liu et al. (2021b) |
| Rabbits | 4 groups: Negative control, positive control, static scaffold group, dynamic scaffold group | Multilayer scaffolds implanted into knee defects in rabbits | Dynamic scaffold showed better osteochondral regeneration compared to the static group | Hu et al. (2022) |
| Rabbits | 3 groups: Control, GelMA scaffold, nHA-GelMA scaffold | Scaffolds implanted into osteochondral defects in rabbit knee joints | nHA-GelMA showed better osteochondral regeneration | Li et al. (2022) |
| Rabbits | 4 groups: Control, Drug-free BRH-CRH, BRH-CRH (no MSCs), BRH-CRH [MSC-encapsulated] | Bilayer BRH-CRH hydrogel scaffolds injected osteochondral defect site | BRH-CRH [MSC-encapsulated] showed better osteochondral integration and cartilage regeneration | Liu et al. (2020) |
| Rabbits | 3 groups: Control, DN material group, DN-3Mg/Cu hydrogel group | Bilayer hydrogels implanted into osteochondral defects in rabbits | DN-3Mg/Cu hydrogel showed better osteochondral regeneration | Luo et al. (2022) |
| Rabbits | 3 groups: Pure GelMA, bilayer GelMA-PDA/HA, bilayer GelMA-PDA/HA with BMP-2 and TGF-β3 | Bilayer hydrogels implanted into osteochondral defects in rabbit knee joints | BMP-2/TGF-β3 showed well-organized cartilage and subchondral bone regeneration | Gan et al. (2019) |
| Nude mice | 2 groups: Acellular scaffold and cell-seeded scaffold (sample) | Cell-seeded scaffolds implanted subcutaneously in nude mice | Staining confirmed tissue-specific regeneration of bone and cartilage in scaffolds | Shalumon et al. (2016) |
| Rabbits | 4 groups: HAp@PLL scaffold, Ta@gel + GelMA@BMSCs, HAp@PLL + hydrogel + GelMA@BMSCs, and HAp@PLL + Ta@gel + GelMA@BMSCs | Composite scaffolds were implanted in 4 mm osteochondral defects in rabbit knee joints | HAp@PLL + Ta@gel + GelMA@BMSCs revealed better osteochondral regeneration | Guo et al. (2024) |
| Rats | 4 groups: Control, GelMA, GelMA/HAp, and GelMA/Eu-HAp | GelMA/Eu-HAp hydrogel was injected into osteochondral defects | GelMA/Eu-HAp showed better cartilage and bone regeneration | Jin et al. (2024) |
| Immunohistochemistry | Inflammation and infection | Degradation of hydrogel | References |
|---|---|---|---|
| Strong positive staining for COL I and AGG in both cartilage and subchondral bone regions in CuTA@SF group | No signs of infection | CuTA@SF degraded almost completely by week 12 than other groups | Cao et al. (2023) |
| Positive staining for COL I and COL II in cartilage and subchondral bone regions, indicating successful tissue repair | No signs of infection | Upper layer degraded faster than lower; neither layer completely degraded after 12 weeks | Lan et al. (2021) |
| Positive COL2 staining in IL-4 scaffold group, indicating cartilage regeneration | No signs of infection | GelMA layer showed gradual degradation over 16 weeks | Gong et al. (2020) |
| COL2 and OCN staining showed significant matrix deposition in cartilage and bone regions in the experimental group | No signs of infection | Gradual degradation of scaffolds over 12 weeks; KGN and AT released during scaffold degradation | Chen et al. (2024) |
| Strong COL II and Aggrecan in cartilage, COL I and Opn in bone for GH@LM + GA@HLM group | No signs of infection | GH@LM + GA@HLM hydrogel gradually degraded over 12 weeks | Hu et al. (2024) |
| Positive staining for collagen II in cartilage and new bone formation in the silk-nanoCaP layer | No signs of infection | Scaffold maintained integrity with no significant mass loss over 4 weeks | Yan et al. (2015) |
| Not reported | Inflammation noted at the scaffold interface | Not explicitly mentioned | Korpayev et al. (2020) |
| Positive staining for COL II in cartilage and COL I in subchondral bone confirmed tissue regeneration | Minimal inflammation observed | Scaffold and thermogel gradually degraded over 3–6 months | Zhang et al. (2022b) |
| Positive COL II staining in cartilage and COL I staining in bone confirmed tissue regeneration | No signs of infection | Gradual degradation of the Zn-AlgMA hydrogel and Mg alloy over the course of the 10-week study | Zhang et al. (2024) |
| Positive COL II and COL I staining confirmed cartilage and bone tissue regeneration in 5–20 DE scaffolds | No signs of infection | Slower degradation observed in DE-incorporated scaffolds, with 5–20 DE showing the slowest rate | Deng et al. (2024) |
| COL II and osteocalcin revealed scaffold #1 (PCL-chit-PEGb) promoted cartilage, while scaffold #2 (anti-CD44) favored bone formation | anti-CD44 exhibited more inflammatory infiltration | Not explicitly mentioned | Filová et al. (2020) |
| Positive staining for COL I and COL II confirmed cartilage and bone tissue regeneration | No signs of infection | Not explicitly mentioned | Liu et al. (2021a) |
| Positive staining for COL II and COL I confirmed tissue regeneration | No signs of infection | Gradual degradation observed over 12 weeks post-implantation | Kang et al. (2024) |
| Positive staining for COL II in cartilage and COL I in subchondral bone confirmed tissue regeneration | No signs of infection | Gradual degradation of the scaffold over 12 weeks, with sustained Mg2+ release | Li et al. (2023a) |
| Positive staining for Aggrecan and COL II confirmed cartilage matrix formation in SF-MMT group | No signs of infection | Gradual degradation of the SF-MMT hydrogel over the course of the 12-week study | Sheng et al. (2022) |
| Positive staining for Runx2 and Sox9 confirmed osteogenic and chondrogenic differentiation in nHApMA scaffolds | No signs of infection | Not explicitly mentioned | Zheng et al. (2023) |
| Positive staining for collagen II confirmed enhanced cartilage regeneration in BSN-GelMA group | No signs of infection | Gradual degradation observed over 12 weeks | Wu et al. (2023) |
| Positive staining for COL II in cartilage and COL I in bone confirmed tissue regeneration | No significant inflammation observed in any group | Gradual degradation over 12 weeks, with good scaffold integration | Li et al. (2023b) |
| Positive staining for collagen II in cartilage and collagen I in bone confirmed tissue regeneration in MagHA groups | No signs of infection | Gradual degradation observed over 12 weeks; slower in MagHA-rich regions | Zhang et al. (2023a) |
| Not applicable | No signs of infection | Not explicitly mentioned | You et al. (2018) |
| Positive staining for COL II in cartilage and COL I in bone confirmed tissue regeneration | No signs of infection | Gradual degradation of GelMA observed over 12 weeks | Zhang et al. (2023b) |
| Not reported | No signs of infection | Gradual degradation observed over 8 weeks | Radhakrishnan et al. (2018) |
| Positive COL II staining confirmed cartilage regeneration in G-nHA + BMSCs group | No signs of infection | Gradual degradation of the scaffold over 12 weeks post-implantation | Zhang et al. (2021) |
| Positive staining for type II collagen confirmed chondrogenesis in HGM groups | No signs of infection | Gradual degradation of HGM hydrogels over 6 weeks | Xu et al. (2019) |
| Positive staining for COL I in subchondral bone and COL II in cartilage confirmed tissue regeneration | No signs of infection | Gradual degradation observed over 12 weeks post-implantation | Liu et al. (2021b) |
| Positive staining for COL II confirmed cartilage matrix formation in dynamic group | No signs of infection | Gradual degradation of the scaffold observed over 12 weeks | Hu et al. (2022) |
| Positive staining for COL II in cartilage and COL I in subchondral bone confirmed tissue regeneration | No signs of infection | Gradual degradation over 12 weeks | Li et al. (2022) |
| Positive staining for COL II in cartilage and COL I in bone confirmed phase-specific tissue regeneration | No signs of infection | Gradual degradation observed over 12 weeks in vivo | Liu et al. (2020) |
| Positive staining for type II collagen and GAG in cartilage, and collagen type I in bone in DN-3Mg/Cu group | No signs of infection | Gradual degradation observed over 12 weeks | Luo et al. (2022) |
| Not reported | No signs of infection | Gradual degradation over 12 weeks | Gan et al. (2019) |
| Positive staining for type I collagen (bone) and type II collagen (cartilage) confirmed osteochondral tissue formation | No signs of infection | Not explicitly mentioned | Shalumon et al. (2016) |
| Positive staining for COL II, ACAN, and SOX9 in cartilage, and COL I, OPN, and OCN in subchondral bone | No signs of infection | Gradual degradation of hydrogel observed, supporting tissue regeneration | Guo et al. (2024) |
| Positive staining for CD206 and Arg1 indicated M2 macrophage polarization in the GelMA/Eu-HAp group | No signs of infection | Gradual degradation of GelMA/Eu-HAp hydrogel observed over time | Jin et al. (2024) |
Experimental models and methods in vivo studies.
Histological assessments across various studies frequently highlighted improved tissue integration. A GTU-Fe/KGN@PDA/miRNA@CaP scaffold led to enhanced chondrogenic and osteogenic marker expression, indicating successful differentiation and maturation of regenerated tissue, with elevated glycosaminoglycans (GAG) and collagen deposition contributing to effective cartilage and bone regeneration (Table 4) (Kang et al., 2024). Further corroborating these findings, a Zn-AlgMA@Mg scaffold achieved significant osteochondral integration, facilitating seamless cartilage repair and trabecular bone formation within femoral condyle defects in rabbits (Zhang et al., 2024) (Table 4). Despite these advancements, scaffold-cartilage integration remains a significant challenge in tissue engineering. Recent strategies to address this issue include manipulating cellular, material, and biomolecular composition of engineered tissue (Jelodari et al., 2022). These findings highlight the potential for improved cartilage repair and integration using advanced scaffolds and tissue engineering techniques.
Many studies achieved substantial subchondral bone regeneration, suggesting that functionalization strategies including the incorporation of miRNAs, bioactive molecules, and structurally adaptive hydrogels play a crucial role in promoting dual regeneration for osteochondral repair. For example, bi-layer hydrogels and trilayered scaffolds demonstrated enhanced bone volume and trabecular thickness, ultimately supporting comprehensive osteochondral regeneration (Lan et al., 2021; Chen et al., 2024). Moreover, these studies predominantly used femoral condyle defect models, effectively showing that nano-hydrogels, when tailored to recreate the native extracellular environment, support robust tissue regeneration over extended periods. Functionalization strategies, such as incorporating tissue-specific peptides or drugs, have shown enhanced chondrogenesis and osteogenesis both in vitro and in vivo (Guo et al., 2021; Chen et al., 2024). These advanced scaffolds have demonstrated improved bone volume, trabecular thickness, and overall defect filling in femoral condyle defect models, supporting comprehensive osteochondral regeneration (Cao et al., 2024; Chen et al., 2024; Guo et al., 2024).
The variability in regenerative outcomes observed across studies, characterized by differing degrees of bone density and cartilage smoothness, highlights the necessity for a standardized approach to evaluating scaffold performance. Future research should focus on adopting consistent animal models, such as femoral defect models, and harmonized assessment criteria, such as specific histological markers and imaging techniques, to enable comparative evaluations across various hydrogel systems. Such standardization could accelerate the translation of nano-hydrogel-based technologies into clinical settings, supporting more predictable outcomes and broader applicability.
3.6 Key limitations in osteochondral repair studies and prospective innovations
Recent advances in osteochondral tissue engineering have focused on developing scaffolds that support cell growth and tissue regeneration. Scaffold degradation plays a crucial role in the repair process, with different degradation modalities and speeds influencing outcomes (Tortorici et al., 2022). Despite considerable advances in osteochondral repair, several critical limitations remain across studies, as outlined in Table 5. One major challenge involves inconsistent degradation rates in scaffold materials. Achieving a uniform degradation timeline has proven difficult, with some hydrogel systems degrading faster than intended, reducing structural support for newly forming tissue, while others degrade too slowly, limiting cell infiltration and impeding tissue remodeling. For instance, study conducted by Adedoyin et al. noted this inconsistency in their dual-gelation scaffold, where uneven degradation impacted overall regenerative outcomes (Adedoyin et al., 2015). To address this, further research should investigate advanced crosslinking techniques to fine-tune degradation kinetics, ensuring scaffold resorption aligns more closely with native tissue growth.
TABLE 5
| Limitations | Future directions | References |
|---|---|---|
| No significant enhancement in mechanical properties; lack of long-term studies | Optimize CuTA concentration; conduct long-term in vivo studies | Cao et al. (2023) |
| Incomplete degradation after 12 weeks; mechanical properties do not match natural tissue | Optimize hydrogel composition; explore long-term repair outcomes | Lan et al. (2021) |
| Study limited to rabbits; need for investigation in larger animals or humans | Study IL-4 mechanisms in osteochondral repair in larger models | Gong et al. (2020) |
| Study limited to rabbits; larger animal models and longer-term studies needed | Investigate drug release mechanisms; test in larger animals | Chen et al. (2024) |
| Lack of biomechanical testing | Expand to larger models and conduct biomechanical tests | Hu et al. (2024) |
| Short-term study (4 weeks) | Investigate long-term effects; optimize mechanical properties | Yan et al. (2015) |
| Short-term in vivo study (14 days) | Conduct longer-term studies on scaffold degradation | Korpayev et al. (2020) |
| Short-term study | Optimize materials for cartilage and bone regeneration rates | Zhang et al. (2022b) |
| No in vivo testing conducted | Focus on in vivo testing for osteochondral repair | Adedoyin et al. (2015) |
| Short-term study (10 weeks) | Conduct long-term studies on degradation and integration | Zhang et al. (2024) |
| Short-term study (12 weeks) | Investigate long-term effects; optimize scaffolds for human use | Deng et al. (2024) |
| Short study duration; inflammatory response from scaffold #2 | Assess long-term effects and optimize modifications to reduce inflammation | Filová et al. (2020) |
| Short-term study; no in vivo testing | Explore in vivo testing and growth factor delivery | Brown et al. (2024) |
| Short-term study | Focus on long-term integration and clinical translation | Liu et al. (2021a) |
| Short-term study | Optimize KGN and miRNA-26a delivery for clinical applications | Kang et al. (2024) |
| Short-term study (12 weeks) | Focus on long-term scaffold integration and degradation | Li et al. (2023a) |
| Short-term study | Investigate long-term integration of the bilayer scaffold | Banihashemian et al. (2024) |
| No long-term in vivo testing | Focus on in vivo regeneration and long-term mechanical performance | Zheng et al. (2014) |
| Long-term effects not assessed | Study long-term regeneration and clinical testing | Sheng et al. (2022) |
| Short-term study | Investigate long-term degradation and regeneration applications | Zheng et al. (2023) |
| Short-term study | Explore clinical translation for osteochondral defects | Wu et al. (2023) |
| Short-term study (12 weeks) | Optimize exosome delivery and test in larger models | Li et al. (2023b) |
| Short-term study; long-term effects not assessed | Explore long-term integration and optimization of stimulation | Zhang et al. (2023a) |
| No long-term in vivo testing; focused on subcutaneous models | Conduct in vivo testing in osteochondral defect models | You et al. (2018) |
| Short-term study | Investigate long-term tissue integration and scaffold degradation | Zhang et al. (2023b) |
| Short-term study | Investigate long-term degradation and larger animal integration | Radhakrishnan et al. (2018) |
| Lack of complete tissue regeneration assessment | Investigate long-term degradation and clinical translation | Zhang et al. (2021) |
| No in vivo studies; long-term effects not assessed | Focus on in vivo testing and scaffold optimization | Kosik-Kozioł et al. (2019) |
| Short-term study; no long-term assessment | Investigate long-term degradation and clinical translation | Xu et al. (2019) |
| No in vivo studies performed | Focus on in vivo testing and full integration for regeneration | Qin et al. (2020) |
| Short-term study | Focus on long-term integration and optimization for regeneration | Liu et al. (2021b) |
| No long-term assessment of degradation | Study long-term degradation and clinical applications | Hu et al. (2022) |
| Short-term study; long-term effects not assessed | Focus on long-term integration and optimization for clinical use | Li et al. (2022) |
| Short-term study; no long-term assessment | Investigate long-term integration and controlled release systems | Liu et al. (2020) |
| No in vivo data | Explore in vivo testing and clinical translation for repair | Fan et al. (2021) |
| Short-term study | Investigate long-term integration and clinical translation | Luo et al. (2022) |
| Short-term study | Focus on long-term integration and mechanical performance | Gan et al. (2019) |
| No in vivo study | Optimize scaffold for osteochondral repair with in vivo testing | Castro et al. (2015) |
| No long-term studies conducted | Focus on long-term degradation and larger model testing | Shalumon et al. (2016) |
| Study limited to short-term evaluation | Explore long-term integration and clinical translation | Guo et al. (2024) |
| Short-term animal study | Optimize hydrogel composition and test in larger models | Jin et al. (2024) |
Summary of study limitations and proposed future directions.
Another prevalent issue is the variability in scaffold mechanical strength, particularly when scaling up for larger defects. Achieving a mechanical resilience that closely mimics native tissue properties remains challenging. Li et al. reported that preserving compressive strength in bilayer scaffolds was difficult over long-term in vivo applications, highlighting a critical need for more durable biomaterials (Li et al., 2023a). Novel scaffold compositions and innovative crosslinked structures could offer the increased load-bearing capacities necessary to provide robust support in osteochondral applications, particularly those involving weight-bearing joints.
Additionally, there is limited long-term in vivo data on the efficacy and safety of these scaffolds. While short-term successes are frequently observed, the potential for chronic inflammation or complications related to scaffold degradation requires longer follow-up. Studies highlight the necessity for prolonged trials to thoroughly assess scaffold stability, biocompatibility, and integration with native tissue structures, all critical for achieving successful clinical translation (Brown et al., 2024; Hu et al., 2024).
To overcome these challenges, future research could focus on innovative materials and scaffold designs. The use of in situ forming hydrogels, which adapt to irregular defect sites during implantation, may enhance scaffold integration (Zheng et al., 2014; Park and Park, 2018; Kang et al., 2024). Smart, stimuli-responsive hydrogels capable of controlled therapeutic release could also support sustained regeneration and more effective clinical outcomes. Additionally, combining nano-hydrogels with synergistic regenerative approaches such as gene therapy, bioelectronics, or cell-based treatments may lead to multifunctional scaffolds that facilitate not only osteogenesis and chondrogenesis but also angiogenesis (Kumar et al., 2022; Chen et al., 2023). Together, these integrated approaches have the potential to advance osteochondral repair, bringing the field closer to scalable, reliable therapeutic solutions.
4 Conclusion
This systematic review underscores the diverse and evolving strategies employed in nano-hydrogel-based scaffolds for osteochondral repair. By systematically stratifying the included studies according to formulation type (injectable vs. preformed), structural design (single-phase, bilayered, trilayered, or gradient), and polymer origin (natural, synthetic, hybrid), we identified key trends linking scaffold architecture to biological performance. Notably, bilayered and trilayered systems that emulate the native osteochondral zonation more effectively support site-specific chondrogenesis and osteogenesis. Similarly, hybrid scaffolds integrating natural and synthetic polymers often demonstrate superior synergy between mechanical strength and bioactivity.
Despite promising preclinical outcomes, translational challenges persist. The field is hindered by variability in fabrication methods, inconsistencies in mechanical robustness and degradation profiles, and a lack of long-term in vivo validation. Moreover, the absence of standardized animal models and outcome measures limits direct comparison across studies, thereby impeding regulatory progression and clinical adoption.
To address these limitations, we propose a scaffold design framework emphasizing biomimetic zoning, controlled delivery of bioactive cues, stimuli-responsive behavior, and compliance with good manufacturing practice (GMP) standards. Comparative evaluations using unified scoring systems, load-bearing models, and long-term functional assessments will be critical to bridge the gap between laboratory innovation and clinical implementation.
In conclusion, while nano-hydrogels offer clear advantages in mimicking the extracellular matrix and modulating the local microenvironment, their future lies in rational design guided by translational benchmarks. With sustained interdisciplinary collaboration and regulatory foresight, these systems have the potential to evolve into clinically viable, patient-specific therapies for osteochondral regeneration.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author contributions
AFA: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Writing – original draft, Writing – review and editing. LQ: Conceptualization, Formal Analysis, Investigation, Resources, Writing – review and editing. HD: Formal Analysis, Investigation, Methodology, Resources, Writing – review and editing. JL: Formal Analysis, Investigation, Methodology, Writing – review and editing. JW: Formal Analysis, Supervision, Writing – review and editing. WW: Supervision, Writing – review and editing. JH: Supervision, Writing – review and editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2025.1611522/full#supplementary-material
References
1
AdedoyinA.KumarR.SridharS.EkenseairA. (2015). Injectable bionanocomposite hybrid scaffolds with responsive control for enhanced osteochondral tissue regeneration. IEEE, Troy, NY, USA, 1–2.
2
AhmadZ.SalmanS.KhanS. A.AminA.RahmanZ. U.Al-GhamdiY. O.et al (2022). Versatility of hydrogels: from synthetic strategies, classification, and properties to biomedical applications. Gels8 (3), 167. 10.3390/gels8030167
3
BanihashemianA.Zamanlui BenisiS.HosseinzadehS.ShojaeiS.AbbaszadehH. (2024). Structural and biological investigation of alginate-nano-hydroxyapatite with chitosan-hyaluronic acid for potential osteochondral regeneration. Int. J. Polym. Mater. Polym. Biomaterials73 (10), 851–865. 10.1080/00914037.2023.2215378
4
BerryD. R.DíazB. K.Durand-SilvaA.SmaldoneR. A. (2019). Radical free crosslinking of direct-write 3D printed hydrogels through a base catalyzed thiol-Michael reaction. Polym. Chem.10 (44), 5979–5984. 10.1039/c9py00953a
5
BradyM. A.TalvardL.VellaA.EthierC. R. (2017). Bio‐inspired design of a magnetically active trilayered scaffold for cartilage tissue engineering. J. tissue Eng. Regen. Med.11 (4), 1298–1302. 10.1002/term.2106
6
BrownN. E.EllerbeL. R.HollisterS. J.TemenoffJ. S. (2024). Development and characterization of heparin-containing Hydrogel/3D-Printed scaffold composites for craniofacial reconstruction. Ann. Biomed. Eng.52, 2287–2307. 10.1007/s10439-024-03530-z
7
CaoD.DingJ. (2022). Recent advances in regenerative biomaterials. Regen. Biomater.9, rbac098. 10.1093/rb/rbac098
8
CaoY.ZhangH.QiuM.ZhengY.ShiX.YangJ. (2024). Biomimetic injectable and bilayered hydrogel scaffold based on collagen and chondroitin sulfate for the repair of osteochondral defects. Int. J. Biol. Macromol.257, 128593. 10.1016/j.ijbiomac.2023.128593
9
CaoZ.WangH.ChenJ.ZhangY.MoQ.ZhangP.et al (2023). Silk-based hydrogel incorporated with metal-organic framework nanozymes for enhanced osteochondral regeneration. Bioact. Mater.20, 221–242. 10.1016/j.bioactmat.2022.05.025
10
CastroN. J.PatelR.ZhangL. G. (2015). Design of a novel 3D printed bioactive nanocomposite scaffold for improved osteochondral regeneration. Cell. Mol. Bioeng.8, 416–432. 10.1007/s12195-015-0389-4
11
CavendishP. A.EverhartJ. S.PetersN. J.SommerfeldtM. F.FlaniganD. C. (2019). Osteochondral allograft transplantation for knee cartilage and osteochondral defects: a review of indications, technique, rehabilitation, and outcomes. JBJS Rev.7 (6), e7. 10.2106/jbjs.rvw.18.00123
12
ChahlaJ.SweetM. C.OkorohaK. R.NwachukwuB. U.HinckelB.FarrJ.et al (2019). Osteochondral allograft transplantation in the patellofemoral joint: a systematic review. Am. J. sports Med.47 (12), 3009–3018. 10.1177/0363546518814236
13
ChanderS.KulkarniG. T.DhimanN.KharkwalH. (2021). Protein-based nanohydrogels for bioactive delivery. Front. Chem.9, 573748. 10.3389/fchem.2021.573748
14
ChenH.HuangJ.LiX.ZhaoW.HuaY.SongZ.et al (2024). Trilayered biomimetic hydrogel scaffolds with dual-differential microenvironment for articular osteochondral defect repair. Mater. Today Bio26, 101051. 10.1016/j.mtbio.2024.101051
15
ChenW.MingY.WangM.HuangM.LiuH.HuangY.et al (2023). Nanocomposite hydrogels in regenerative medicine: applications and challenges. Macromol. Rapid Commun.44 (15), 2300128. 10.1002/marc.202300128
16
DavisS.RoldoM.BlunnG.TozziG.RoncadaT. (2021). Influence of the mechanical environment on the regeneration of osteochondral defects. Front. Bioeng. Biotechnol.9, 603408. 10.3389/fbioe.2021.603408
17
De Leon-OlivaD.BoaruD. L.Perez-ExpositoR. E.Fraile-MartinezO.García-MonteroC.DiazR.et al (2023). Advanced hydrogel-based strategies for enhanced bone and cartilage regeneration: a comprehensive review. Gels9 (11), 885. 10.3390/gels9110885
18
DengC.QinC.LiZ.LuL.TongY.YuanJ.et al (2024). Diatomite-incorporated hierarchical scaffolds for osteochondral regeneration. Bioact. Mater.38, 305–320. 10.1016/j.bioactmat.2024.05.004
19
DinoroJ.MaherM.TalebianS.JafarkhaniM.MehraliM.OriveG.et al (2019). Sulfated polysaccharide-based scaffolds for orthopaedic tissue engineering. Biomaterials214, 119214. 10.1016/j.biomaterials.2019.05.025
20
DongZ.YuanQ.HuangK.XuW.LiuG.GuZ. (2019). Gelatin methacryloyl (GelMA)-based biomaterials for bone regeneration. RSC Adv.9 (31), 17737–17744. 10.1039/c9ra02695a
21
FanZ.ChenZ.ZhangH.NieY.XuS. (2021). Gradient mineralized and porous double‐network hydrogel effectively induce the differentiation of BMSCs into osteochondral tissue in vitro for potential application in cartilage repair. Macromol. Biosci.21 (3), 2000323. 10.1002/mabi.202000323
22
FilováE.TonarZ.LukášováV.BuzgoM.LitvinecA.RampichováM.et al (2020). Hydrogel containing anti-CD44-labeled microparticles, guide bone tissue formation in osteochondral defects in rabbits. Nanomaterials10 (8), 1504. 10.3390/nano10081504
23
GanD.WangZ.XieC.WangX.XingW.GeX.et al (2019). Mussel‐inspired tough hydrogel with in situ nanohydroxyapatite mineralization for osteochondral defect repair. Adv. Healthc. Mater.8 (22), 1901103. 10.1002/adhm.201901103
24
GeckilH.XuF.ZhangX.MoonS.DemirciU. (2010). Engineering hydrogels as extracellular matrix mimics. Nanomedicine5 (3), 469–484. 10.2217/nnm.10.12
25
GongL.LiJ.ZhangJ.PanZ.LiuY.ZhouF.et al (2020). An interleukin-4-loaded bi-layer 3D printed scaffold promotes osteochondral regeneration. Acta Biomater.117, 246–260. 10.1016/j.actbio.2020.09.039
26
GoughJ. E.SaianiA.MillerA. F. (2012). Peptide hydrogels: mimicking the extracellular matrix. Bioinspired, Biomim. Nanobiomaterials1 (1), 4–12. 10.1680/bbn.11.00007
27
GuoC.SuZ.ZhaoL.ChenR.WangY.WuY.et al (2024). Customized triphasic cartilage composite scaffold simulating hypoxic microenvironment for osteochondral regeneration. Compos. Part B Eng.271, 111161. 10.1016/j.compositesb.2023.111161
28
GuoJ. L.KimY. S.KoonsG. L.LamJ.NavaraA. M.BarriosS.et al (2021). Bilayered, peptide-biofunctionalized hydrogels for in vivo osteochondral tissue repair. Acta Biomater.128, 120–129. 10.1016/j.actbio.2021.04.038
29
GuoJ. L.LiA.KimY. S.XieV. Y.SmithB. T.WatsonE.et al (2020). Click functionalized, tissue‐specific hydrogels for osteochondral tissue engineering. J. Biomed. Mater. Res. Part A108 (3), 684–693. 10.1002/jbm.a.36848
30
HamedE.LeeY.JasiukI. (2010). Multiscale modeling of elastic properties of cortical bone. Acta Mech.213 (1), 131–154. 10.1007/s00707-010-0326-5
31
HjelleK.SolheimE.StrandT.MuriR.BrittbergM. (2002). Articular cartilage defects in 1,000 knee arthroscopies. Arthrosc. J. Arthrosc. and Relat. Surg.18 (7), 730–734. 10.1053/jars.2002.32839
32
HuC.HuangR.XiaJ.HuX.XieD.JinY.et al (2024). A nanozyme-functionalized bilayer hydrogel scaffold for modulating the inflammatory microenvironment to promote osteochondral regeneration. J. nanobiotechnology22 (1), 445. 10.1186/s12951-024-02723-x
33
HuW.WangZ.XiaoY.ZhangS.WangJ. (2019). Advances in crosslinking strategies of biomedical hydrogels. Biomaterials Sci.7 (3), 843–855. 10.1039/c8bm01246f
34
HuX.ZhengS.ZhangR.WangY.JiaoZ.LiW.et al (2022). Dynamic process enhancement on chitosan/gelatin/nano-hydroxyapatite-bone derived multilayer scaffold for osteochondral tissue repair. Biomater. Adv.133, 112662. 10.1016/j.msec.2022.112662
35
HwangH. S.LeeC.-S. (2024). Nanoclay-composite hydrogels for bone tissue engineering. Gels10 (8), 513. 10.3390/gels10080513
36
JelodariS.Ebrahimi SadrabadiA.ZareiF.JahangirS.AzamiM.SheykhhasanM.et al (2022). New insights into cartilage tissue engineering: improvement of tissue‐scaffold integration to enhance cartilage regeneration. BioMed Res. Int.2022 (1), 7638245. 10.1155/2022/7638245
37
JinY.ShuM.LiuZ.LiH.LiuC.ZhuC.et al (2024). Bio-functional immunomodulatory europium-doped hydroxyapatite nanorods for osteochondral repair via CDH5-RAS-RAF-MEK-ERK-CSF1 axis. Chem. Eng. J.484, 149311. 10.1016/j.cej.2024.149311
38
KangJ.LiY.QinY.HuangZ.WuY.SunL.et al (2024). In situ deposition of drug and gene nanoparticles on a patterned supramolecular hydrogel to construct a directionally osteochondral plug. Nano-Micro Lett.16 (1), 18. 10.1007/s40820-023-01228-w
39
KorpayevS.KaygusuzG.ŞenM.OrhanK.OtoÇ.KarakeçiliA. (2020). Chitosan/Collagen based biomimetic osteochondral tissue constructs: a growth factor-free approach. Int. J. Biol. Macromol.156, 681–690. 10.1016/j.ijbiomac.2020.04.109
40
Kosik-KoziołA.CostantiniM.MrózA.IdaszekJ.HeljakM.JaroszewiczJ.et al (2019). 3D bioprinted hydrogel model incorporating β-tricalcium phosphate for calcified cartilage tissue engineering. Biofabrication11 (3), 035016. 10.1088/1758-5090/ab15cb
41
KumarA.SoodA.SinghmarR.MishraY. K.ThakurV. K.HanS. S. (2022). Manufacturing functional hydrogels for inducing angiogenic–osteogenic coupled progressions in hard tissue repairs: prospects and challenges. Biomaterials Sci.10 (19), 5472–5497. 10.1039/d2bm00894g
42
LanW.XuM.QinM.ChengY.ZhaoY.HuangD.et al (2021). Physicochemical properties and biocompatibility of the bi-layer polyvinyl alcohol-based hydrogel for osteochondral tissue engineering. Mater. and Des.204, 109652. 10.1016/j.matdes.2021.109652
43
LeeJ. H. (2018). Injectable hydrogels delivering therapeutic agents for disease treatment and tissue engineering. Biomaterials Res.22 (1), 27. 10.1186/s40824-018-0138-6
44
LiC.ZhangW.NieY.JiangD.JiaJ.ZhangW.et al (2023a). Integrated and bifunctional bilayer 3D printing scaffold for osteochondral defect repair. Adv. Funct. Mater.33 (20), 2214158. 10.1002/adfm.202214158
45
LiM.SongP.WangW.XuY.LiJ.WuL.et al (2022). Preparation and characterization of biomimetic gradient multi-layer cell-laden scaffolds for osteochondral integrated repair. J. Mater. Chem. B10 (22), 4172–4188. 10.1039/d2tb00576j
46
LiQ.YuH.ZhaoF.CaoC.WuT.FanY.et al (2023b). 3D printing of microenvironment‐specific bioinspired and exosome‐reinforced hydrogel scaffolds for efficient cartilage and subchondral bone regeneration. Adv. Sci.10 (26), 2303650. 10.1002/advs.202303650
47
LiuK.LiuY.DuanZ.MaX.FanD. (2021a). A biomimetic bi-layered tissue engineering scaffolds for osteochondral defects repair. Sci. China Technol. Sci.64 (4), 793–805. 10.1007/s11431-020-1597-4
48
LiuP.LiM.YuH.FangH.YinJ.ZhuD.et al (2021b). Biphasic CK2. 1-coated β-glycerophosphate chitosan/LL37-modified layered double hydroxide chitosan composite scaffolds enhance coordinated hyaline cartilage and subchondral bone regeneration. Chem. Eng. J.418, 129531. 10.1016/j.cej.2021.129531
49
LiuX.ChenY.MaoA. S.XuanC.WangZ.GaoH.et al (2020). Molecular recognition-directed site-specific release of stem cell differentiation inducers for enhanced joint repair. Biomaterials232, 119644. 10.1016/j.biomaterials.2019.119644
50
LiuY.HsuS.-H. (2018). Synthesis and biomedical applications of self-healing hydrogels. Front. Chem.6, 449. 10.3389/fchem.2018.00449
51
LowenJ. M.WheelerE. E.ShimamotoN. K.Ramos‐RodriguezD. H.GriffinK. H.BondG. C.et al (2024). Functionalized annealed microgels for spatial control of osteogenic and chondrogenic differentiation. Adv. Funct. Mater.34, 2311017. 10.1002/adfm.202311017
52
LuoM.ChenM.BaiJ.ChenT.HeS.PengW.et al (2022). A bionic composite hydrogel with dual regulatory functions for the osteochondral repair. Colloids Surfaces B Biointerfaces219, 112821. 10.1016/j.colsurfb.2022.112821
53
LynchC. R.KondiahP. P.ChoonaraY. E. (2021). Advanced strategies for tissue engineering in regenerative medicine: a biofabrication and biopolymer perspective. Molecules26 (9), 2518. 10.3390/molecules26092518
54
MacleodM. R.O’collinsT.HowellsD. W.DonnanG. A. (2004). Pooling of animal experimental data reveals influence of study design and publication bias. Stroke35 (5), 1203–1208. 10.1161/01.str.0000125719.25853.20
55
ManoJ.ReisR. (2007). Osteochondral defects: present situation and tissue engineering approaches. J. tissue Eng. Regen. Med.1 (4), 261–273. 10.1002/term.37
56
MartinI.MiotS.BarberoA.JakobM.WendtD. (2007). Osteochondral tissue engineering. J. biomechanics40 (4), 750–765. 10.1016/j.jbiomech.2006.03.008
57
MoherD.LiberatiA.TetzlaffJ.AltmanD. G.PrismaG. T. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med.151 (4), 264–269. 10.7326/0003-4819-151-4-200908180-00135
58
MoherD.ShamseerL.ClarkeM.GhersiD.LiberatiA.PetticrewM.et al (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev.4, 1–9. 10.1186/2046-4053-4-1
59
NguyenL. H.KudvaA. K.SaxenaN. S.RoyK. (2011). Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel. Biomaterials32 (29), 6946–6952. 10.1016/j.biomaterials.2011.06.014
60
ParkK. M.ParkK. D. (2018). In situ cross-linkable hydrogels as a dynamic matrix for tissue regenerative medicine. Tissue Eng. Regen. Med.15, 547–557. 10.1007/s13770-018-0155-5
61
PaulA.ManoharanV.KrafftD.AssmannA.UquillasJ. A.ShinS. R.et al (2016). Nanoengineered biomimetic hydrogels for guiding human stem cell osteogenesis in three dimensional microenvironments. J. Mater. Chem. B4 (20), 3544–3554. 10.1039/c5tb02745d
62
QiaoZ.LianM.HanY.SunB.ZhangX.JiangW.et al (2021). Bioinspired stratified electrowritten fiber-reinforced hydrogel constructs with layer-specific induction capacity for functional osteochondral regeneration. Biomaterials266, 120385. 10.1016/j.biomaterials.2020.120385
63
QinY.LiG.WangC.ZhangD.ZhangL.FangH.et al (2020). Biomimetic bilayer scaffold as an incubator to induce sequential chondrogenesis and osteogenesis of adipose derived stem cells for construction of osteochondral tissue. ACS Biomaterials Sci. and Eng.6 (5), 3070–3080. 10.1021/acsbiomaterials.0c00200
64
QuaziM. Z.ParkN. (2022). Nanohydrogels: advanced polymeric nanomaterials in the era of nanotechnology for robust functionalization and cumulative applications. Int. J. Mol. Sci.23 (4), 1943. 10.3390/ijms23041943
65
RadhakrishnanJ.ManigandanA.ChinnaswamyP.SubramanianA.SethuramanS. (2018). Gradient nano-engineered in situ forming composite hydrogel for osteochondral regeneration. Biomaterials162, 82–98. 10.1016/j.biomaterials.2018.01.056
66
RanaM. M.De La Hoz SieglerH. (2024). Evolution of hybrid hydrogels: next-generation biomaterials for drug delivery and tissue engineering. Gels10 (4), 216. 10.3390/gels10040216
67
SethiS.MedhaT. S.SinghA.KaithB. S.KhullarS. (2023). Handbook of green and sustainable nanotechnology: fundamentals, developments and applications. Springer Nature, 1–31.
68
ShalumonK.SheuC.FongY. T.LiaoH.-T.ChenJ.-P. (2016). Microsphere-based hierarchically juxtapositioned biphasic scaffolds prepared from poly (lactic-co-glycolic acid) and nanohydroxyapatite for osteochondral tissue engineering. Polymers8 (12), 429. 10.3390/polym8120429
69
ShengR.ChenJ.WangH.LuoY.LiuJ.ChenZ.et al (2022). Nanosilicate‐reinforced silk fibroin hydrogel for endogenous regeneration of both cartilage and subchondral bone. Adv. Healthc. Mater.11 (17), 2200602. 10.1002/adhm.202200602
70
SoniS. S.D'eliaA. M.AlsasaA.ChoS.TylekT.O'brienE. M.et al (2022). Sustained release of drug-loaded nanoparticles from injectable hydrogels enables long-term control of macrophage phenotype. Biomaterials Sci.10 (24), 6951–6967. 10.1039/d2bm01113a
71
SuvarnapathakiS.WuX.LantiguaD.NguyenM. A.Camci‐UnalG. (2020). Hydroxyapatite‐incorporated composite gels improve mechanical properties and bioactivity of bone scaffolds. Macromol. Biosci.20 (10), 2000176. 10.1002/mabi.202000176
72
TomalW.OrtylJ. (2020). Water-soluble photoinitiators in biomedical applications. Polymers12 (5), 1073. 10.3390/polym12051073
73
TortoriciM.PetersenA.DudaG. N.ChecaS. (2022). The degradation of synthetic polymeric scaffolds with strut-like architecture influences the mechanics-dependent repair process of an osteochondral defect in silico. Front. Bioeng. Biotechnol.10, 846665. 10.3389/fbioe.2022.846665
74
VerhagenR. A.StruijsP. A.BossuytP. M.Van DijkC. N. (2003). Systematic review of treatment strategies for osteochondral defects of the talar dome. Foot ankle Clin.8 (2), 233–242. 10.1016/s1083-7515(02)00064-5
75
VilelaC.CorreiaC.OliveiraJ. M.SousaR. A.Espregueira-MendesJ.ReisR. L. (2015). Cartilage repair using hydrogels: a critical review of in vivo experimental designs. ACS Biomaterials Sci. and Eng.1 (9), 726–739. 10.1021/acsbiomaterials.5b00245
76
WangH.HuB.LiH.FengG.PanS.ChenZ.et al (2022a). Biomimetic mineralized hydroxyapatite nanofiber-incorporated methacrylated gelatin hydrogel with improved mechanical and osteoinductive performances for bone regeneration. Int. J. NanomedicineVol. 17, 1511–1529. 10.2147/ijn.s354127
77
WangS.QiuY.QuL.WangQ.ZhouQ. (2022b). Hydrogels for treatment of different degrees of osteoarthritis. Front. Bioeng. Biotechnol.10, 858656. 10.3389/fbioe.2022.858656
78
WeiG.MaP. X. (2008). Nanostructured biomaterials for regeneration. Adv. Funct. Mater.18 (22), 3568–3582. 10.1002/adfm.200800662
79
WuH.ShangY.SunW.OuyangX.ZhouW.LuJ.et al (2023). Seamless and early gap healing of osteochondral defects by autologous mosaicplasty combined with bioactive supramolecular nanofiber-enabled gelatin methacryloyl (BSN-GelMA) hydrogel. Bioact. Mater.19, 88–102. 10.1016/j.bioactmat.2022.03.038
80
XiangC.ZhangX.ZhangJ.ChenW.LiX.WeiX.et al (2022). A porous hydrogel with high mechanical strength and biocompatibility for bone tissue engineering. J. Funct. Biomaterials13 (3), 140. 10.3390/jfb13030140
81
XuJ.FengQ.LinS.YuanW.LiR.LiJ.et al (2019). Injectable stem cell-laden supramolecular hydrogels enhance in situ osteochondral regeneration via the sustained co-delivery of hydrophilic and hydrophobic chondrogenic molecules. Biomaterials210, 51–61. 10.1016/j.biomaterials.2019.04.031
82
YanL.-P.Silva-CorreiaJ.OliveiraM. B.VilelaC.PereiraH.SousaR. A.et al (2015). Bilayered Silk/silk-nanoCaP scaffolds for osteochondral tissue engineering: in vitro and in vivo assessment of biological performance. Acta Biomater.12, 227–241. 10.1016/j.actbio.2014.10.021
83
YangW.ZhuP.HuangH.ZhengY.LiuJ.FengL.et al (2019). Functionalization of novel theranostic hydrogels with kartogenin-grafted USPIO nanoparticles to enhance cartilage regeneration. ACS Appl. Mater. and interfaces11 (38), 34744–34754. 10.1021/acsami.9b12288
84
YangY.XuT.ZhangQ.PiaoY.BeiH. P.ZhaoX. (2021). Biomimetic, stiff, and adhesive periosteum with osteogenic–angiogenic coupling effect for bone regeneration. Small17 (14), 2006598. 10.1002/smll.202006598
85
YaoH.WangC.ZhangY.WanY.MinQ. (2023). Manufacture of bilayered composite hydrogels with strong, elastic, and tough properties for osteochondral repair applications. Biomimetics8 (2), 203. 10.3390/biomimetics8020203
86
YouB.LiQ.DongH.HuangT.CaoX.LiaoH. (2018). Bilayered HA/CS/PEGDA hydrogel with good biocompatibility and self-healing property for potential application in osteochondral defect repair. J. Mater. Sci. and Technol.34 (6), 1016–1025. 10.1016/j.jmst.2017.11.016
87
YueS.HeH.LiB.HouT. (2020). Hydrogel as a biomaterial for bone tissue engineering: a review. Nanomaterials10 (8), 1511. 10.3390/nano10081511
88
ZenginA.CastroJ.HabibovicP.Van RijtS. (2021). Injectable, self-healing mesoporous silica nanocomposite hydrogels with improved mechanical properties. Nanoscale13 (2), 1144–1154. 10.1039/d0nr07406c
89
ZhangH.HuangH.HaoG.ZhangY.DingH.FanZ.et al (2021). 3D printing hydrogel scaffolds with nanohydroxyapatite gradient to effectively repair osteochondral defects in rats. Adv. Funct. Mater.31 (1), 2006697. 10.1002/adfm.202006697
90
ZhangH.LiQ.XuX.ZhangS.ChenY.YuanT.et al (2022a). Functionalized microscaffold–hydrogel composites accelerating osteochondral repair through endochondral ossification. ACS Appl. Mater. and interfaces14 (47), 52599–52617. 10.1021/acsami.2c12694
91
ZhangL.DaiW.GaoC.WeiW.HuangR.ZhangX.et al (2023a). Multileveled hierarchical hydrogel with continuous biophysical and biochemical gradients for enhanced repair of full‐thickness osteochondral defect. Adv. Mater.35 (19), 2209565. 10.1002/adma.202209565
92
ZhangP.ChenJ.SunY.CaoZ.ZhangY.MoQ.et al (2023b). A 3D multifunctional bi-layer scaffold to regulate stem cell behaviors and promote osteochondral regeneration. J. Mater. Chem. B11 (6), 1240–1261. 10.1039/d2tb02203f
93
ZhangY.DongQ.ZhaoX.SunY.LinX.ZhangX.et al (2024). Honeycomb-like biomimetic scaffold by functionalized antibacterial hydrogel and biodegradable porous Mg alloy for osteochondral regeneration. Front. Bioeng. Biotechnol.12, 1417742. 10.3389/fbioe.2024.1417742
94
ZhangY.HanY.PengY.LeiJ.ChangF. (2022b). Bionic biphasic composite scaffolds with osteochondrogenic factors for regeneration of full-thickness osteochondral defects. Biomaterials Sci.10 (7), 1713–1723. 10.1039/d2bm00103a
95
ZhengL.JiangX.ChenX.FanH.ZhangX. (2014). Evaluation of novel in situ synthesized nano-hydroxyapatite/collagen/alginate hydrogels for osteochondral tissue engineering. Biomed. Mater.9 (6), 065004. 10.1088/1748-6041/9/6/065004
96
ZhengS.LiD.LiuQ.TangC.HuW.MaS.et al (2023). Surface-modified nano-hydroxyapatite uniformly dispersed on high-porous GelMA scaffold surfaces for enhanced osteochondral regeneration. Int. J. NanomedicineVol. 18, 5907–5923. 10.2147/ijn.s428965
97
ZhuD.TongX.TrinhP.YangF. (2018). Mimicking cartilage tissue zonal organization by engineering tissue-scale gradient hydrogels as 3D cell niche. Tissue Eng. Part A24 (1-2), 1–10. 10.1089/ten.tea.2016.0453
Summary
Keywords
nano-hydrogel, osteochondral repair, tissue engineering, biomaterials, osteochondral
Citation
Amhare AF, Qiao L, Deng H, Lin J, Wang J, Wang W and Han J (2025) The current status of nano-hydrogel preparations for osteochondral repair: Systematic Review. Front. Bioeng. Biotechnol. 13:1611522. doi: 10.3389/fbioe.2025.1611522
Received
14 April 2025
Accepted
23 June 2025
Published
01 July 2025
Volume
13 - 2025
Edited by
Dongxu Ke, Wake Forest University, United States
Reviewed by
Yogendra Pratap Singh, VIT University, India
Miguel Fuentes Chandia, Case Western Reserve University, United States
Updates
Copyright
© 2025 Amhare, Qiao, Deng, Lin, Wang, Wang and Han.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Wang, dr.wangwei@xjtu.edu.cn; Jing Han, bbbishop@126.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.